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Summary 
Sepsis-associated encephalopathy (SAE) is the most common form of encephalopathy oc-
curring in critical care settings and refers to acute neurological dysfunction that arises in the 
context of extracranial sepsis. SAE is an early feature of infection in the body, occurs quite 
often with a prevalence of up to 30% in septicemic patients at admission and SAE severity is 
associated with increased mortality of septic patients. Although the symptoms of SAE are well 
recognized - it can take the form of delirium, coma, seizures, or late cognitive decline - its 
pathophysiology is incompletely understood.  
Although pathophysiology of SAE has not been established, several likely mechanisms 
have been proposed. The hallmarks are thought to comprise diffuse neuroinflammation likely 
driven by initial blood-brain barrier (BBB) leakage leading to microglial activation and altered 
neurotransmission. Activation of brain microvascular endothelial cells as the primary constitu-
ent of the BBB is regarded as an early event, induced by interaction with pathogen product like 
LPS via pattern recognition receptors and proinflammatory factors. 
Microglial cells as the main cell population of resident immune-competent cells in the CNS 
are activated early after infection-induced systemic inflammation. Cross talk between resident 
immune cells in the brain, the vascular endothelium and circulating leukocytes probably is re-
sponsible for the major part of microglial activation during sepsis. Once activated, microglia 
exhibit a spectrum of phenotypes and functions to either exacerbate brain injury or to induce 
repair and regeneration, depending on different molecular signals received by the microglial 
receptors. Therefore, a wide variety of partly opposing responses have been described for acti-
vated microglia and associated with SAE pathophysiology; however, underlying signal trans-
duction pathways are hitherto poorly characterized and appropriate specific treatment options 
are missing. 
Phosphoinositide 3-kinase γ (PI3Kγ) was originally characterized as a signaling protein 
mediating G protein-coupled receptor stimulation by its enzymatic activity to produce phospha-
tidylinositol 3,4,5-trisphosphate for downstream protein kinase B/Akt activation. Subsequent 
studies revealed that PI3Kγ attenuates the cAMP/PKA pathway by working as an activator of 
phosphodiesterases, which hydrolyze cAMP to 5′-AMP. Recently, we have disclosed PI3Kγ as 
a key mediator of microglial cell functions at different pathologies including SAE.  
Thermoregulation is a fundamental homeostatic function of all mammals that includes three 
components: afferent thermal sensing, central regulation, and an efferent response. Lower devi-
ation of core body temperature (Tc) outside a small physiological range of circadian variation 
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lead to rigorous autonomic thermoregulatory responses, mainly driven by a gradually increased 
sympathetic tone, in order to minimize radiant heat loss by skin vasoconstriction and maximize 
heat production by brown adipose tissue thermogenesis. Recent data clearly indicate that poor 
outcome of sepsis is associated with spontaneous Tc lowering (hypothermia, indicating for en-
ergy exhaustion) or fever inducing high energy cost as additional physiological challenges in 
patients with septic life-threatening conditions. Subgroups of patients with increased risk to 
develop sepsis such as trauma or burns are endangered for cold challenge leading frequently to 
accidental hypothermia. However, role of challenged thermoregulation upon exposition at re-
duced ambient temperature (Ta) and possibly resulting accidental hypothermia in pathogenesis 
of SAE has not been studied. 
The aim of this study was to examine the specific role of reduced Ta exposition with proba-
bly enhanced sympathetic tone on BBB dysfunction induced by systemic inflammation at the 
organismic, organ and molecular level. 
Experiments were performed in PI3Kγ wild-type, knockout, and kinase-dead mice, which 
were kept at neutral (30±0.5 °C) or moderately lowered (26±0.5 °C) Ta. Mice were exposed to 
LPS-induced SIRS and monitored for thermoregulatory response and blood-brain barrier 
(BBB) integrity. Primary microglial cells and brain tissue derived from treated mice were ana-
lysed for inflammatory responses and related cell functions.  
We found that a moderate reduction of Ta led to enhanced hypothermia of mice undergoing 
LPS-induced SIRS accompanied by aggravated SIRS-induced SAE. The data showed an in-
creased BBB disruption under reduced Ta after LPS stimulation, especially in PI3Kγ
-/- 
mice
 
compared to WT and PI3KγKD/KD mice. PI3Kγ deficiency enhances BBB injury and upregula-
tion of matrix metalloproteinases (MMPs) as well as an impairment of microglial phagocytic 
activity. 
This study reveals that enhanced adaptive thermoregulatory mechanisms in response to 
temperatures below the thermoneutral range of Ta and lead to exacerbated LPS-induced BBB 
injury and accompanied neuroinflammation. The signaling protein PI3Kγ was characterized as 
a critical mediator of key microglial cell functions involved in LPS-induced BBB injury and 
accompanied neuroinflammation. PI3Kγ serves a protective role in that it suppresses MMP 
release, maintains microglial motility and reinforces phagocytosis leading to improved brain 
tissue integrity.  
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Zusammenfassung 
Sepsis-assoziierte Enzephalopathie (SAE) ist die häufigste Eenzephalopathie-Form, die bei 
kritisch kranken Patienten auftritt und stellt eine akute neurologische Dysfunktion bei extrakra-
nieller Sepsis dar. SAE ist ein frühes Merkmal einer systemischen Infektion, weist eine hohe 
Prävalenz bei septischen Patienten schon bei Erstvorstellung (bei bis zu 30%) auf und ist mit 
erhöhter Mortalität septischer Patienten assoziiert. Obgleich die SAE-Symptome eindeutig 
festgestellt werden können (Delirium, Koma, Krämpfe oder späte kognitive Einschränkung), ist 
die Pathophysiologie der SAE immer noch inkomplett aufgeklärt. 
Die Pathophysiologie der SEA bislang ist unzureichend aufgeklärt. Jedoch sind eine Reihe 
wahrscheinlicher Mechanismen inzwischen postuliert worden. Der entscheidende Schädi-
gungsmechanismus besteht offensichtlich in dem Auftreten einer diffuse Neuroinflammation, 
die wahrscheinlich hervorgerufen wird durch eine initiale Schädigung der Blut-Hirnschranke 
(BHS). Dies hat eine Mikroglia-Aktivierung und eine veränderte Neurotransmission zur Folge. 
Eine Aktivierung der zerebralen mikrovaskulären Endothelzellen als primärer BHS- Bestand-
teil wird dabei als frühes Ereignis angesehen, das durch Interaktion mit pathogenen Substanzen 
wie z. B LPS via Stimulation von sog. Pattern Recognition Rezeptoren (PRR) bzw. anderen 
proinflammatorischen Faktoren induziert wird. 
Mikroglia-Zellen als die Hauptpopulation residenter immunkompetenter Zellen des ZNS 
werden schon früh nach Induktion einer infektions-induzierten systemischen Entzündungsreak-
tion aktiviert. Wechselseitige Interaktionen zwischen den residenten Immunzellen des Gehirns, 
dem Gefäßendothel und zirkulierende Leukozyten sind augenscheinlich hauptsächlich für die 
mikrogliale Aktivierung bei Sepsis verantwortlich. Aktivierte Mikrogliazellen zeigen ein 
Spektrum verschiedener Phänotypen und Funktionen, die entweder zu einer Verschlimmerung 
der Hirnschädigung beitragen können, oder Reparatur- und Regenerationsprozesse unterstützen. 
Dies hängt von der Art und Intensität einer großen Vielzahl molekularer Signale ab. Insgesamt 
wurde bislang eine breite Palette von z.T. gegensätzlichen Reaktionsmustern von aktivierten 
Mikrogliazellen beschrieben, die als assoziiert  mit der SAE-Pathophysiologie gelten. Bislang 
sind jedoch die zugrunde liegenden Signaltransduktionswege kaum charakterisiert und spezifi-
sche Therapieoptionen fehlen gänzlich. 
Phosphoinositid 3-kinase γ (PI3Kγ) wurde initial als G-Protein-gekoppeltes Signalprotein 
charakterisiert, das nach Stimulation mit seiner Enzymaktivität durch Produktion von Phos-
phatidylinositol 3,4,5-trisphosphat zur Aktivierung der Proteinkinase B/Akt führt. Nachfolgen-
de Untersuchungen wiesen nach, dass PI3Kγ den cAMP/PKA-Signalweg durch Aktivierung 
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von Phosphodiesterasen, die cAMP zu 5‘-AMP hydrolisieren, inhibieren kann. In letzter Zeit 
wurde von unserer Arbeitsgruppe nachgewiesen, dass PI3Kγ eine Schlüsselstellung bei der 
Vermittlung mikrogliärer Zellfunktionen zukommt, die bei einer Reihe verschiedener Erkran-
kungen einschließlich der SAE bedeutsam sind. 
Die Thermoregulation ist eine fundamentale homöostatische Funktion aller Säugetiere, die 
drei Komponenten einschließt: Die afferente Temperaturwahrnehmung, die zentrale Regulation 
und eine efferente Vermittlung der regulatorischen Antwort. Variationen der Körperkerntempe-
ratur (KKT) außerhalb des engen physiologischen Bereiches der zirkadianen Schwankungen 
führt zu erheblichen autonomen thermoregulatorischen Reaktionen, die hauptsächlich durch 
graduelle Steigerung des Sypathikotonus vermittelt werden und zu einer Minimierung des 
Wärmeverlustes durch Vasokonstrikion der Hautgefäße und Maximierung der Wärmeprodukti-
on durch metabolische Thermogenese führen. Aktuelle Daten belegen, dass eine Verschlechte-
rung des Outcomme bei Sepsis mit spontaner Unterschreitung der KKT (Hypothermie, das eine 
energetische Erschöpfung anzeigt), oder Fieber (mit erhöhtem Energiebedarf) assoziiert ist. 
Eine Aktivierung der Thermoregulation stellt offensichtlich eine ungünstige zusätzliche Anfor-
derung an Patienten mit lebensbedrohlichen Erkrankungen dar. Patientengruppen mit einem 
erhöhten Risiko für Sepsis (z. B. Trauma- oder Verbrennungspatienten) sind insbesondere ge-
fährdet, eine Unterkühlung zu erleiden. Dies führt sehr häufig zu akzidenteller Hypothermie. 
Die pathogenetische Bedeutung von verstärkter Thermoregulation infolge verminderter Umge-
bungstemperatur und die gegebenenfalls hervorgerufenen Folgen einer akzidentellen Hypo-
thermie für die Pathogenese der SAE wurden bisher nicht untersucht.  
Ziel der vorliegenden Untersuchung bestand darin, aufzuklären, ob einer reduzierten Um-
gebungstemperatur (d.h. Unterschreiten der Neutralzone) mit dadurch induzierter Erhöhung des 
Sympathikotonus eine eigenständige Bedeutung in der Pathogenese einer BHS-Schädigung 
infolge systemischer Inflammation zukommt.   
Die Experimente wurden an PI3Kγ Wildtype, Knockout (PI3Kγ-/-) and Kinase-Dead 
(PI3KγKD/KD)-Mäusen durchgeführt, die entweder bei neutraler (30±0.5 °C) oder moderat ver-
minderter (26±0.5 °C) Umgebungstemperatur gehalten wurden. Bei den Mäusen wurde durch 
LPS-Gabe eine systemische Inflammation (SIRS) induziert. Die thermoregulatorischen Reakti-
onen wurden fortlaufend telemetrisch und am Versuchsende hinsichtlich der BHS-Integrität 
erfasst. Außerdem wurden in Zellkultur-Untersuchungen an primären Mikrogliazellen und im 
Hirngewebe behandelter Mäuse Reaktionsmuster induzierter Neuroinflammation und zugehö-
riger Zellfunktionen analysiert. 
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Wir konnten nachweisen, dass eine moderate Verminderung der Umgebungstemperatur zu 
verstärkter Hypothermie bei LPS-induzierter SIRS und einer Verschlimmerung der SIRS-
induzierten SAE führt. Weiterhin konnte gezeigt werden, dass es zu einer verstärkten BHS-
Schädigung insbesondere bei PI3Kγ-/--Mäusen im Vergleich mit Wildtyp- und PI3KγKD/KD-
Mäusen kommt. PI3Kγ –Defizit verstärkte die BHS-Schädigung, führte zur verstärkten Upre-
gulation von Matrix-Metalloproteinasen und beeinträchtigte die mikrogliale Phagozytose-
Aktivität. 
Durch diese Untersuchung konnte nachgewiesen werden, dass eine verstärkte Aktivierung 
adaptiver Thermoregulationsmechanismen infolge Unterschreitung der Neutralzone der Umge-
bungstemperatur eine Exazerbation der LPS-induzierten BHS-Schädigung und zugehörigen 
neuroinflammatorischen Antwort zur Folge hat. Das Signalprotein PI3Kγ konnte als wesentli-
cher Vermittler von Schlüsselfunktionen der Mikroglia bei LPS-induzierter BHS-Schädigung 
und zugehörigen neuroinflammatorischen Reaktionen charakterisiert werden.  
Aus den vorliegenden Ergebnissen kann die Schlussfolgerung gezogen werden, dass das 
Signalprotein PI3Kγ als protektiver Faktor wirksam wird, indem die Freisetzung von Mat-
rixmetalloproteinasen supprimiert und die mikrogliale Motilität bzw. Phagozytoseaktivität auf-
rechterhalten wird. 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
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1.1. Sepsis - brief historical overview, current definition and incidence 
Sepsis is one of the oldest and most elusive syndromes described in medicine. With the 
confirmation of the germ theory by Semmelweis, Pasteur, and others, sepsis was recast as a 
systemic infection, often described as “blood poisoning” and assumed to be the result of the 
host's invasion by pathogenic organisms that then spread by the bloodstream. Before that, Hip-
pocrates firstly claimed that sepsis was the process by which flesh rots, swamps generate foul 
airs, and wounds fester and Galen later considered sepsis a laudable event, necessary for wound 
healing (Funk et al. 2009; Majno 1991). However, even with the advent of modern antibiotics 
consequently to the discovery of pathogenic organism’s involvement; germ theory did not fully 
explain the pathogenesis of sepsis: many patients with sepsis died despite successful eradica-
tion of the inciting pathogen. Thus, researchers suggested that it was mainly the host response, 
not just the germ violence that drove the pathogenesis of sepsis (Cerra 1985). In 1992, an inter-
national consensus panel defined sepsis as a systemic inflammatory response syndrome (SIRS) 
which is frequently caused by infection (Stearns-Kurosawa et al. 2011). Furthermore, septice-
mia was neither a necessary condition nor a helpful term (Bone et al. 1992). According to the 
classical definition of sepsis, which was used until two years ago, sepsis diagnosis requires the 
recognition of the SIRS, which is frequently caused by infection (Stearns-Kurosawa et al. 
2011). For a long time, when SIRS occurred with infection, the diagnosis for the patient was 
sepsis, and the severity of the disease depended on its association with organ dysfunction, hy-
poperfusion or hypotension. In particular, patients met the criteria for septic shock when they 
had persistent hypotension and perfusion abnormalities despite adequate fluid resuscitation 
(Levy et al. 2003). Ongoing advances in molecular biology have provided keen insight into the 
complexity of pathogen and alarm recognition by the human host and important clues to a host 
response that has gone awry (Angus and van der Poll 2013). Progress in clinical and transla-
tional sepsis research is meanwhile continuously reviewed and consecutively transferred into 
guidelines in order to improve sepsis diagnosis and therapy (Dellinger et al. 2013).  
Meanwhile, the recognition has prevailed that development of organ dysfunction discrimi-
nates sepsis from uncomplicated infection. Consequently, the appearance of the new sepsis-3 
definition, published two years ago, prompted a reappraisal of organ dysfunction as the hall-
mark of sepsis. Sepsis is now defined as life-threatening organ dysfunction caused by a dysreg-
ulated host response to infection (Singer et al. 2016). Nevertheless, the complex pathogenesis 
of sepsis remains insufficiently explored and resulting therapeutic concepts are hitherto fre-
quently unable to treat curatively patient suffered from sepsis and septic shock. A complex and 
dynamic interaction exists between pathogens and host immune-defence mechanisms during 
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the course of invasive infection. It is now widely thought that the host response to sepsis in-
volves many, concomitant, integrated, and often antagonistic processes that involve both exag-
gerated inflammation and immune suppression. It has become apparent that infection triggers a 
complex, variable, and prolonged host response, in which both proinflammatory and anti-
inflammatory mechanisms can contribute to clearance of infection and tissue recovery or organ 
injury and secondary infections (Angus and van der Poll 2013). Several novel mediators result-
ing from disturbed host tissue and pathways have been shown to play a part. Moreover, evi-
dence is accumulating that microbial virulence and bacterial load contribute to the host re-
sponse and the outcome of severe infections (van der Poll and Opal 2008). Improved integra-
tive understanding is needed to distinguish the hierarchy of the various mechanisms underlying 
multi-organ failure as a key consequence of severe sepsis often causative for fatal outcome 
(Bauer et al. 2018; Rudiger et al. 2008). 
Sepsis and septic shock remain major challenges in medicine. Mortality rate is high and its 
incidence is increasing worldwide (Angus and van der Poll 2013). Recent data from Germany 
revealed a sustained high number of 88,000 patients with so-called severe sepsis or septic 
shock in 2011 in German hospitals, with associated hospital mortality rates of 43% for severe 
sepsis and 60% for septic shock, respectively (Heublein et al. 2013).  
The clinical process usually begins with infection, which potentially leads to organ dysfunc-
tion following a continuum of severity from sepsis or septic shock leading to multiple organ 
dysfunction (MOD) and probably death (Gustot 2011). Organ dysfunction or organ failure 
caused by a dysregulated host response to infection is now defined to be the characteristic clin-
ical sign of sepsis, as mentioned above (Singer et al. 2016); and no organ system is immune 
from the consequences of the inflammatory excesses induced by an uncontrolled infection. 
However, the molecular mechanisms that underlie organ failure in sepsis have been only par-
tially elucidated.  
Currently, new conceptual thinking is focusing on sepsis as a pathogen-induced imbalance 
of host damage and repair processes that trigger failure of either resistance or “disease tolerance” 
mechanisms (Bauer et al. 2018; Medzhitov et al. 2012). These mechanisms provide tissue dam-
age control and repair to sustain host tissue integrity and organ function even without reducing 
pathogen (Kotas and Medzhitov 2015; Soares et al. 2014).  
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1.2. Sepsis-associated encephalopathy 
Sepsis-associated encephalopathy (SAE) is characterized as diffuse brain dysfunction oc-
curring in response to an organismic infection but accompanies in the absence of direct CNS 
infection, structural abnormality or other types of encephalopathy (Gofton and Young 2012). 
Importantly, SAE is a highly relevant clinical problem with a prevalence of up to 30% in septi-
cemic patients at admission. Depending on the study, 30-70% of in-hospital patients with sepsis 
and SIRS develop SAE (Ebersoldt et al. 2007; Siddiqi et al. 2006). Consequently, the currently 
recommended score to identify patients with suspected infection who are at risk of sepsis as a 
life-threatening organ dysfunction due to a dysregulated host response to infection, the quick 
Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) score, include estimation of 
altered mentation as one out of three clinical criteria (Seymour et al. 2016). 
Intriguingly, a relevant part of sepsis survivors suffers from long-term cognitive deficits, 
(impaired attention and memory as well as verbal fluency difficulties). Therefore, sepsis is a 
great risk for developing new permanent neurocognitive dysfunction especially in the elderly 
affecting their ability to live independently (Semmler et al. 2013; Widmann and Heneka 2014). 
Till now no specific biomarker exists for SAE and it remains therefore a clinical diagnosis 
(Gofton and Young 2012). SAE manifests as a spectrum of disturbed cerebral function ranging 
from mild delirium to coma. As mortality is increased with severity of SAE (Zhang et al. 2012), 
early identification and management of patients with SAE are important to reduce associated 
morbidity and mortality. Patients presenting with SAE show evidence of severe systemic infec-
tion with features of sepsis or SIRS (Young et al. 1990). Cerebral dysfunction seen in SAE re-
flects the systemic metabolic, inflammatory and haemodynamic disturbances that are associat-
ed with SIRS, rather than a direct CNS abnormality (Fig. 1). Nevertheless, detailed pathophysi-
ology of SAE has not been completely understood (Gofton and Young 2012; Tauber et al. 
2017).  
In general, SAE pathophysiology involves BBB dysfunction and neuroinflammation caused 
by endothelial and microglial activation induced by endogenous or pathogen-derived com-
pounds. Furthermore, hypoxia by impaired microvascular regulation and septic shock as well as 
imbalance of neurotransmitters contributes to SAE severity (Mazeraud et al. 2016).  
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Figure 1. Pathophysiology of sepsis-associated encephalopathy.  
Three mechanisms contribute to SAE: (I) Systemic cytokines enter the CNS either by specific transporter 
uptake or via the disturbed BBB or directly via the circumventricular organs (CVOs), induce the activation of 
microglial cells, which leads to further BBB breakdown and neuronal apoptosis, (II) impaired autoregulation 
lead to reduced vascular reactivity and cerebral blood flow dysfunction, (III) imbalance of neurotransmitters. 
GABA: gamma-aminobutyric acid. Adopted from (Tauber et al. 2017). 
 
1.2.1. BBB disturbance and neuroinflammation at SAE onset - Role of PI3Kγ  
Infection-induced response of systemic inflammation is thought to be mainly responsible 
for SAE initiation due to BBB breakdown. This pathological process is triggered by an early 
and overwhelming release of proinflammatory cytokines from innate immune cells triggered by 
microbial particles (PAMPs - pathogen-associated molecular patterns) and recognized by toll-
like receptors (TLRs) and other pattern recognition receptors (PRRs) (Ebersoldt et al. 2007; 
Laflamme and Rivest 2001). The hallmark of early SAE propagation is thought to be a diffuse 
neuroinflammation driven by microglial activation due to BBB leakage leading to direct cellu-
lar neuronal damage. Subsequently, significant deterioration of brain endothelial tight junctions 
allows invasion of blood-born immunocompetent cells and corresponding proinflammatory 
reinforcement (Nag et al. 2011). Because our experimental study presented herein is focused on 
the early manifestation period of SAE, we will restrict the detailed description of the known 
SAE pathogenesis on this period of disease. 
Till now, it is partly understood how a systemic inflammation affects the brain and leads to 
SAE, considering that the healthy brain is well protected to the outside by the BBB. The barrier 
10 
 
functions of the capillary bed of the brain are known to arise from three modifications: the 
presence of tight junctions between endothelial cells (ECs), a near absence of macropinocytosis, 
and loss of fenestrae (Brightman and Reese 1969; O'Brown et al. 2018; Reese and Karnovsky 
1967). 
It has been shown that the fraction of circulating bacterial product entering the brain via un-
affected BBB appears to be low (Banks and Robinson 2010). Nevertheless, these mouse studies 
showed that LPS uptake into the brain (dosages comparable with usually used doses to induce 
SIRS by intraperitoneal application) is high enough to activate brain parenchymal TLR4 recep-
tors. Therefore, microglial cells at the surveillance state appears to be prone to become activat-
ed during the initial period of SIRS by direct interaction with low dose PAMPs originated from 
extracerebral sources. 
However, interaction between microbial particles (acting as PAMPs) with the luminal sur-
face of cerebral endothelial cells - as an integral BBB component - contribute to the mediation 
of neuroinflammatory response considerably because about 75%, of the circulating LPS that 
does interact with the BBB is reversibly binding to the luminal surface of the BBB leading to 
activate the ECs (Banks and Robinson 2010). In consequence, a considerable vasodilation and 
serum protein extravasation appeared already 4 hours after LPS application indicating BBB 
breakdown, caused by NO synthase (NOS) activation (Mayhan 1998). Furthermore, cerebral 
ECs express Toll-like receptors (TLRs) which are themselves by oxidative stress and TNFα 
(Nagyoszi et al. 2010) and are activated to release proinflammatory cytokines, including TNFα 
and IL-1β in both luminal and abluminal directions (Erickson and Banks 2018; Nagyoszi et al. 
2015). Intriguingly, cerebral ECs secrete various cytokines in a polarized manner, i.e., response 
to neuroimmune stimulation by LPS occurred more robustly when applied abluminal than did 
luminal LPS administration (Verma et al. 2006). Therefore, activated ECs contribute directly to 
initial promotion of neuroinflammation in virtue of peripheral infection.  
Another relevant pathways responsible for early propagation of SIRS-induced neuroin-
flammation are considered to be a transcytic vesicular transport of blood-born macromolecules 
(i.e., PAMPs or cytokines) though the BBB (Esen et al. 2012; Lossinsky and Shivers 2004) and 
cytokine transport across the BBB in the blood-to-brain direction by way of saturable transport 
systems (Banks and Erickson 2010). The latter involve facilitated diffusion and receptor-
mediated transcytosis as well as energy-requiring, non-vesicular or pore-dependent transport. 
The transport systems for major proinflammatory cytokines are constitutively expressed, selec-
tive and receptor-mediated as well as cytokines use different routes to enter brain tissue (Banks 
2005): Therefore, these immune response modulating cytokines like IL-1β and TNFα, which 
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are not normally circulating in blood, are immediately transported across BBB to transfer the 
information of a peripheral innate immune response to an establishing infection into the brain. 
The resulting neuroinflammatory response appears to be complex and involves behavioral al-
terations (called sickness behaviors (Dantzer et al. 2008)) and activation of immune competent 
cells within the neurovascular unit (NVU). 
Microglia are resident macrophages of the CNS, represent an integral NVU component and 
constitute about 5-20% of all cells in the CNS (Kettenmann et al. 2011; Lawson et al. 1990). A 
hallmark of microglia is their rapid activation after a CNS insult, resulting in their migration 
toward injury, proliferation, and their change in morphology. They take on a more “amoeboid” 
shape with shorter and thicker processes and display increased immunoreactivity for Iba-1 
(Greter et al. 2015).  
Previous work in our lab revealed that PI3Kγ, a signaling protein constitutively expressed 
in immune competent cells (Wetzker and Rommel 2004), play a crucial role in controlling in-
flammatory response in microglial cells. Few years ago, we and others showed that PI3Kγ is 
expressed in microglial cells and is upregulated under proinflammatory conditions (Jin et al. 
2010; Schmidt et al. 2013). Ongoing own work revealed that mainly the lipid kinase independ-
ent function of PI3Kγ (detailed explanation, see below) was responsible for the immune modu-
lating activity of PI3Kγ. Indeed, it could be shown that - with exception of its migration-
stimulating effect (Schneble et al. 2017b) - control of cAMP signaling was responsible for sup-
pressive effects of proinflammatory cell functions in activated microglial cells in cell culture as 
well as in mouse models of several serious diseases. Our group characterized the PI3Kγ - medi-
ated stimulation of cAMP phosphodiesterase activity as a crucial factor of microglial phagocy-
tosis (Schmidt et al. 2013). Subsequent studies on SIRS-induced neuroinflammation revealed 
the lipid kinase independent function of PI3Kγ as a crucial mediator of microglial cell activa-
tion, MMP expression and activation with subsequent BBB deterioration (Frister et al. 2014). 
Parallel investigations on in vivo and in vitro models of brain ischemia have shown that PI3Kγ 
is essential for microglial cAMP regulation under such pathological conditions and its loss pro-
voked an increased MMP-9 expression and suppressed phagocytic activity leading to enhanced 
brain damage after focal brain ischemia (Schmidt et al. 2016).  
Therefore, suppressive effect of PI3Kγ on cAMP levels appears critical for the restriction of 
overwhelming neuroinflammatory activity of microglial cells and its consequences for en-
hanced brain injury. 
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1.3. Role of ambient temperature for homeothermy in mice and men 
Thermoregulation is a fundamental homeostatic function of all mammals that is governed 
by the CNS in homeothermic animals. In humans, body temperature is therefore tightly con-
trolled within a narrow range of 0.2-0.4 °C by coordinated hypothalamic functions. The central 
thermoregulatory system also functions for host defense from invading pathogens by elevating 
body core temperature, a response known as fever. In order to warrant homeothermism, three 
components are established: afferent thermal sensing, central regulation, and an efferent re-
sponse (Nakamura 2011). Thermoregulation involves therefore a variety of involuntary effector 
responses, such as non-shivering thermogenesis in brown adipose tissue, shivering thermogene-
sis in skeletal muscles, thermoregulatory cardiac regulation, heat-loss regulation through cuta-
neous vasomotion, sweating, piloerection and metabolic regulation via endocrine control regu-
lated by adrenocorticotropic hormone (ACTH) release. To defend thermal homeostasis from 
environmental thermal challenges, feedforward thermosensory information on environmental 
temperature sensed by skin thermoreceptors ascends through the spinal cord to the preoptic 
area (POA) of the hypothalamus. Variations in Tc outside this range lead to autonomic ther-
moregulatory responses, mainly driven by a gradual modulation of the sympathetic tone 
(Charkoudian and Wallin 2014).  
Homoeothermic living organisms spend a certain part of energy to maintain Tc. However, 
the percentage varies considerably and depends basically from body surface area to mass ratio 
and whole body thermal conductance. Therefore, mice compared to (naked) human beings have 
to invest about 10 times more energy for this purpose (Gordon 2012). Intriguingly, both species 
share a similar rage of ambient temperature (Ta, 28-32 °C), where the energy expenditure is 
minimal (thermoneutral zone, TNZ). Mouse have a ~7-fold higher mass-specific metabolic rate 
than human beings (Schreiber et al. 2017; West et al. 1997). Nevertheless, mice are just able to 
stabilize Tc under thermoneutral Ta by help of periodic motor activity. Indeed, during sleep Tc 
goes down by 1-2 °C within around 1h which then induces arousal and a short period of exer-
cise provokes an appropriate Tc upgrade ((Jhaveri et al. 2007), own unpublished observations). 
Underrun as well overrun of TNZ result in immediate and increasing energy expenditure, 
which may influence time course and severity of potentially life-threatening diseases such as 
sepsis (Schortgen 2012). Interestingly, there are different strategies to respond on Ta challenges 
in mice and human beings. Heat stress can be effectively handled by men with sweating which 
allows living and working at Ta higher than Tc. However, mice develop hyperthermia already 
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when Ta transcended TNZ by 2 °C (Gordon 2009) and further increase in Ta will enhance dan-
ger for life-threatening heatstroke (Leon et al. 2010).  
In contrast, a shortfall of the lower critical temperature (LCT) of TNZ, that means the 
threshold for activation of a regulatory response by the thermoregulatory system where addi-
tional heat must be generated to meet the demand for increased heat loss (~29 °C), discloses 
mice to be considerably more effective and use additional mechanisms to save energy as it is 
possible for human beings. Mice are able to stabilize Tc in a Ta range of 18-28 °C, but just 
mildly reduced at Ta of 12 °C and 4 °C (Abreu-Vieira et al. 2015). There is a continuous in-
crease of food intake and energy expenditure of ~50% more when Ta was reduced to 22 °C and 
~120% at a Ta of 4 °C (Abreu-Vieira et al. 2015; Gordon et al. 2017). In human beings homeo-
thermy is quite tightly regulated. Therefore, a maximal heat production is initiated with ~5fold 
increase of O2 consumption - mainly by shivering - already at a beginning hypothermia (Tc 
reduction of ~1 °C) (Eyolfson et al. 2001; Sessler 2016). Therefore, accidental (mild) hypo-
thermia due to undercooling or in consequence from disturbed thermoregulation is prone to 
worsen time course and severity of serious diseases like trauma, burns or sepsis mainly because 
of enhanced energy exhaustion (Cumming et al. 2001; Schortgen 2012; Soreide 2014).  
A serious difference in thermoregulatory performance between mice and men consists in 
different response on mild to moderate hypothermia, e.g. the reduction of Tc between 35 and 
28 °C. Whereas human beings develop serious cardiovascular, renal, cerebral and respiratory 
disturbances including coagulopathies, immune suppression and life-threatening cardiac ar-
rhythmias (Brown et al. 2012; Danzl and Pozos 1994), healthy mice are able to cope with hypo-
thermia < 25 °C due to starvation or hypoxia as a principle of energy saving (torpor) (Jensen et 
al. 2013; Overton and Williams 2004; Swoap 2008).  
Despite their more efficient ability to cope with cold stress, mice are valuable animal mod-
els for preclinical studies in order to evaluate the impact of environmental conditions, especial-
ly Ta on time course and pathophysiology of serious diseases like systemic inflammation and 
sepsis. They fulfill with their feature to develop no serious complications like arrhythmias or 
bleedings due to hypothermia a cardinal prerequisite of a model: simplification. Furthermore, 
they allow a causal interpretation of potential different phenotypes by usage of targeted mutants.  
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1.4. Phosphatidylinositol 3-kinases 
1.4.1. The PI3K family  
Phosphatidylinositol 3-kinases (PI3Ks) are members of a unique and conserved family of 
enzymes responsible for the phosphorylation of proteins and lipids. Few information are avail-
able about the protein kinase function of PI3Ks (Thomas et al. 2013), while the lipid kinase 
activity of these enzymes has been extensively studied (Vanhaesebroeck et al. 2010). PI3Ks 
function is to phosphorylate phosphatidyl-inositol lipids at the D3 position of the inositol ring 
(Cantley 2002). PI3Ks are usually activated in response to cell stimulation by growth factors 
and hormones, and they contribute to many intracellular processes including cell survival, cell 
proliferation, metabolism, cell growth, migration and intracellular trafficking (Engelman et al. 
2006; Hirsch et al. 2007). PI3K-produced 3-phosphoinositides regulate intracellular processes 
through the recruitment of signaling proteins at the plasma membrane, whereby they become 
activated (Cantley 2002). 
According to their lipid substrate preferences and to their structural features, PI3Ks are di-
vided into three classes (Class I, Class II and Class III) based on their structural and biochemi-
cal features (Leevers et al. 1999; Vanhaesebroeck et al. 2010).  
Vps34, was found to encode a PI3-kinase that specifically PtdIns at the D-3 position of the 
inositol ring to produce PtdIns3P is the only known member of class III PI3K and it is also the 
only PI3K expressed in all eukaryotic cells (Leevers et al. 1999). Class II PI3Ks includes three 
catalytic isoforms (C2α, C2β, and C2γ), but their functions are less well understood. Class II 
PI3K catalyzes the production of PIP from PI and the production of phosphatidylinositol (3,4)-
bisphosphate (PIP2) from phosphatidylinositol 3-phosphate (PIP). Although recent studies have 
pointed to a role of class II and III PI3Ks in vesicular trafficking (Franco et al. 2014) and cell 
growth (Odorizzi et al. 2000), class I PI3Ks still represent the best characterized subfamily. 
Class I PI3Ks, in vivo, primarily convert phosphatidylinositol-4,5-bisphosphate (PIP2) into 
phosphatidylinositol-3,4,5-trisphosphate (PIP3), which interacts with numerous signaling pro-
teins with pleckstrin-homology (PH) domains. Thus, PIP3 is known to bring the protein serine-
threonine kinases Akt (alternatively called protein kinase B, PKB) and phosphoinositide-
dependent kinase 1 (PDK1) into proximity, facilitating Akt phosphorylation (Alessi et al. 1996). 
Activated Akt phosphorylates and regulates compound proteins, such as glycogen synthase 
kinase 3 beta (GSKβ), forkhead-box-protein O (FOXO) and others, thus triggering multiple 
intracellular signaling cascades (Cantley 2002; Engelman et al. 2006). All these PI3K-induced 
signaling pathways are controlled and limited by protein phosphatases, which degrade PIP3. Of 
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note, Src homology 2 (SH2)-containing-phosphatases (SHIP1 and SHIP2) and phosphatase and 
tensin homolog (PTEN) dephosphorylate PIP3 in positions D5 and D3 respectively, thus termi-
nating PI3K signaling (Cantley 2002; Laurent et al. 2014). 
All class I PI3Ks are heterodimers of a p110 catalytic subunit and a regulatory subunit. De-
pending on the activation mechanism and the differential association with regulatory subunits, 
class I PI3Ks have been grouped in two subfamilies, class IA and class IB (Engelman et al. 
2006; Vanhaesebroeck et al. 2010; Vanhaesebroeck et al. 1997). Class IA catalytic subunits 
(p110α, p110β and p110δ) bind to the p85 type of regulatory subunits, containing SH2 domains 
which are able to bind phosphorylated tyrosine on receptor tyrosine kinases (RTKs) (Burke and 
Williams 2013). On the contrary, class IB catalytic subunit (p110γ) binds two other regulatory 
subunits, p101 and p84/87, which facilitate the direct binding with Gβγ subunit of trimeric G 
proteins (Stephens et al. 1997) (Fig. 2).  
 
Figure 2. Brief overview of PI3Kγ structure and function  
Detailed description is referred in the text; GPCR, G protein coupled-receptor; PDE, Phosphodiesterase; 
MEK, mitogen-activated protein kinase (MAP) kinase; ERK, extracellular-signal-regulated kinase; PTEN, 
phosphatase and tensin homolog; SHIP, SH2-containing inositol 5-phosphatase, adopted from (Ruckle et al. 
2006).  
 
1.4.2. PI3Kγ: Kinase-dependent and -independent functions 
As mentioned above, PI3Kγ is the only member of class IB family (Stoyanov et al. 1995). 
Its lipid kinase activity generates PIP3 to recruit and activate downstream signaling molecules 
in order to mediate a wide variety of biological processes, such as inflammation, cardiac re-
modeling, dendritic cell migration, thrombus formation and allergic responses (Costa et al. 
2011; Hirsch et al. 2000; Nienaber et al. 2003; Wymann and Solinas 2013). It can be activated 
by G protein coupled receptors (GPCR) (Hirsch et al. 2000) or also by pro-inflammatory cyto-
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kines (Johnson et al. 2004). PI3Kγ activation is mediated by the interaction of its catalytic do-
main with the βγ-subunits of G proteins or Ras. Some proteins including Ras, mitogen-
activated protein kinase (MAPK), phosphodiesterases (PDE), p101 and p84, are able to bind to 
PI3Kγ, indicating a protein-scaffold function activating other signaling molecules by protein-
protein interaction (Hirsch et al. 2009). Remarkably, PI3Kγ enzyme can form a multiprotein 
complex containing cAMP-degrading phosphodiesterases, thus negatively regulating cAMP 
pools (Patrucco et al. 2004; Schmidt et al. 2013). Specifically, it has been shown in cardiomyo-
cytes that PI3Kγ directly interacts with the phosphodiesterase 3B (PDE3B) isoform, thus con-
trolling cAMP-induced heart contractility (Patrucco et al. 2004). Furthermore, could be shown 
that the suppressive effect of PI3Kγ on  the intracellular cAMP level of microglial cells appears 
critical for the restriction of overwhelming immune functions in virtue of different acute brain 
injuries (Frister et al. 2014; Schmidt et al. 2016). 
Altogether, these studies underlined that there is a connection between PI3Kγ kinase-
dependent and -independent functions, previously described as distinct signaling pathways. 
However, the interaction partners identified to date provide only a hint of a potentially larger 
set of associations and their functional relevance. New studies will be essential to help uncover 
additional binding partners of PI3Kγ in health and disease. 
 
1.4.3. Role of PI3Kγ in microglial function 
As the immune-competent cells of the brain, microglia play an increasingly important role 
in maintaining normal brain function. They invade the brain early in development, transform 
into a highly ramified phenotype, and constantly screen their environment (Nimmerjahn et al. 
2005). Microglia are activated by any type of pathologic event or change in brain homeostasis. 
This activation process is highly diverse and depends on the context and type of the stressor or 
pathology (Kettenmann et al. 2011; Wolf et al. 2017).  
Based on previous studies of our group and others, PI3Kγ is constitutively expressed in mi-
croglial cells, which suggest that PI3Kγ is an important mediator in microglia functions. Mi-
croglial cells represent the first line of brain cells which respond on any disturbances of cere-
bral homeostasis. They are morphologically dynamic cells whose morphological changes occur 
by pathological events in the CNS. Activated microglial cells are capable of migration, phago-
cytosis, proliferation, reactive oxygen species (ROS) production and the production of various 
cytokines (Hanisch and Kettenmann 2007). In our previous studies, wild-type (WT), PI3Kγ 
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knockout (PI3Kγ-/-) (Hirsch et al. 2000) and PI3Kγ kinase-dead (PI3KγKD/KD) mice (Patrucco et 
al. 2004) were used to clarify the lipid kinase dependent and/or independent function of PI3Kγ. 
Previous investigations have shown that PI3Kγ act as a vital mediator in microglial ROS for-
mation, MMPs production, phagocytosis and migration (Frister et al. 2014; Schmidt et al. 2013; 
Schneble et al. 2017b). It has been shown that PI3Kγ aggravates the microglial migration 
through the lipid kinase-dependent pathway (Schneble et al. 2017b). Furthermore, our findings 
revealed that the loss of PI3Kγ can enhance BBB disturbance and subsequently increase MMPs 
expression via lipid kinase-independent control of cAMP in microglial cells (Frister et al. 2014). 
Results in PI3Kγ-/- mice and PI3KγKD/KD mice also indicate PI3Kγ-dependent suppression of 
cAMP signaling as a critical regulatory element of microglial phagocytosis (Schmidt et al. 
2013). Altogether, these findings imply that the suppressive effect of PI3Kγ on cAMP-
mediated signaling is mainly responsible for an alleviation of some key features of neuroin-
flammatory activity in activated microglial cells (Gyoneva and Traynelis 2013), while keeping 
in mind the anti-inflammatory effect on “resting” microglia induced by -adrenergic stimula-
tion (Feinstein et al. 2002; Gyoneva and Traynelis 2013). 
 
1.5. Objectives and aim of this study 
SAE is a diffuse brain dysfunction which is associated with severe sepsis and has a negative 
influence on survival. The CNS is one of the first organs affected during sepsis, the primary 
symptom is a disturbed level of consciousness (Gofton and Young 2012; Molnar et al. 2018). 
The pathogenesis of SAE includes BBB dysfunction, excessive microglial activation, local 
generation of pro-and anti-inflammatory cytokines and further proinflammatory events 
(Papadopoulos et al. 2000; Sonneville et al. 2013). Recent data clearly indicate that poor out-
come of sepsis is associated with spontaneous Tc lowering (hypothermia, indicating for energy 
exhaustion) or fever inducing high energy cost as additional physiological challenges in pa-
tients with septic life-threatening conditions (Clemmer et al. 1992; Schortgen 2012; Young et al. 
2012). Subgroups of patients with increased risk to develop sepsis such as trauma or burns are 
endangered for cold challenge leading frequently to accidental hypothermia (Cumming et al. 
2001; Soreide 2014). However, role of challenged thermoregulation upon exposition at reduced 
Ta and possibly resulting accidental hypothermia in pathogenesis of SAE has not been studied. 
The aim of this study was to examine the specific role of reduced Ta exposition with proba-
bly enhanced sympathetic tone on BBB dysfunction induced by systemic inflammation at the 
organismic, organ and molecular level.  
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In order to examine different traits of PI3Kγ signaling on microglial activation, migration 
and phagocytic activity, PI3Kγ-deficient mice and mice carrying a targeted mutation in the 
PI3Kγ gene causing loss of lipid kinase activity habituated to neutral or reduced Ta exposition 
were used to induce SIRS by intraperitoneal endotoxin/LPS administration. Mechanistic con-
siderations were intended to characterize involved signaling pathways using brain tissue assays 
and immunohistochemical techniques as well as primary cell cultures and were performed to 
probe putative pathways that could reconcile the physiological and molecular mechanisms of 
cold adaptation and SAE.  
We hypothesize that reduced Ta led to enhanced hypothermia early after LPS induced sys-
temic inflammation. 
Enhanced thermoregulatory response in virtue of reduced Ta may increase elevated sympa-
thetic stimulation during the early period of SIRS.  
Previous own studies showed that adrenergic signaling was a key mediator for aggravated 
BBB disturbance owing to LPS-induced SIRS (Frister et al. 2014). Therefore, we assume that a 
postulated enhancement of the sympathetic activity should provoke a further exacerbation of 
BBB breakdown in mice kept under reduced Ta.   
Microglial cells as resident immune-competent cells of brain parenchyma are known to play 
a significant pathogenetic role during the early period of SAE manifestation (Frister et al. 2014) 
and exhibit a constitutive expression as well as an established signaling and control of cell 
functions of PI3Kγ (Frister et al. 2014; Schmidt et al. 2013; Schneble et al. 2017b). Therefore, 
we will focus our mechanistic studies on this cell population  
In addition, it should be clarified if PI3Kγ lipid-kinase dependent and/or independent mech-
anisms are able to mediate suppression of microglial inflammatory response induced by LPS-
induced SIRS.  
For that purpose, a well-characterized mouse model of infection-induced SIRS by intraperi-
toneal endotoxin/LPS injection was used, which is suited for mechanistic studies with time-
critical requirements (Buras et al. 2005). PI3Kγ wild-type, knockout, and kinase-dead mice 
were exposed to LPS-induced SIRS and assessed for sickness symptoms (Gonnert et al. 2011; 
Ndongson-Dongmo et al. 2015), Tc dynamics, BBB integrity, and microglial cell functions 
(migration, phagocytosis). Additionally, primary microglial cells derived from the respective 
mouse genotypes were used for mechanistic analysis of PI3Kγ effects on microglial inflamma-
tory response.  
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2. Materials and Methods 
2.1. Materials 
2.1.1. Chemicals 
The chemicals used for experiments of this study were listed in Table 1. A Millipore Syner-
gy UV system (Millipore, USA) was used for the preparation of all the buffers. Unless other-
wise stated, all buffers were diluted in double deionized water.  
Phosphate-buffered saline solution (PBS: 137mM NaCl, 2.7mM KCl, 1.8mM KH2PO4, 
10mM Na2HPO4, pH7.5) was used as the basis for various solutions, as washing buffer in vari-
ous applications and for cell culture. The composition of all other buffers and solutions was 
described in the respective protocols. 
Table 1. List of chemicals 
Chemicals Purpose of use Company 
DMEM Cell culture Sigma (USA) 
Fetal bovine serum Cell culture Biowest (FRA) 
Pen/strep Cell culture Sigma (USA) 
Amphotericin B Cell culture Sigma (USA) 
Trypsin Cell culture 
Thermo Fisher 
Scientific (USA) 
EDTA Cell culture Sigma (USA) 
Dnase Cell culture 
Thermo Fisher 
Scientific (USA) 
HEPES Cell culture Roth (GER) 
NaCl Cell culture/IHC Roth (GER) 
KCl Cell culture/IHC Sigma (USA) 
KH2PO4 Cell culture/IHC Roth (GER) 
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Na2HPO4 Cell culture/IHC Roth (GER) 
Poly-L-Lysine IHC Sigma (USA) 
Tween 20 IHC Serva (GER) 
PFA IHC Fischar (GER) 
Paraffin IHC Merck (GER) 
Tri-sodium citrate (dihydrate) IHC Fluka (GER) 
Xylene IHC Roth (GER) 
NDS IHC Sigma (USA) 
BSA-c IHC Sigma (USA) 
Fluoromount IHC 
Southern Biotech 
(USA) 
Isoflurane Mouse CP-Pharma (THA) 
Evan´s Blue Mouse Sigma (USA) 
Zymosan Phagocytosis assay 
Thermo Fisher 
Scientific (USA) 
Crystal Violet Migration assay Sigma (USA) 
 
2.1.2. Substances for Stimulation and Antibodies 
The substances for stimulation and antibodies used for mouse experiments and histolo-
gy/immunohistochemistry are listed in Table 2 and Table 3.   
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Table 2. List of substances for stimulation 
Stimuli  Target Dilution Company  
LPS Mice 10mg/kg body weight Sigma (USA) 
LPS Cells  100ng/ml Sigma (USA) 
C5a Cells 10ng/ml Sigma (USA) 
 
Table 3. List of antibodies 
Target molecule Purpose of use Source Dilution Species / type 
MMP-9 IHC Cell Signaling (USA) 1:150 Rabbit polyclonal 
PMN IHC 
ACCURATE CHEMI-
CAL & SCIENTIFIC 
CO (USA) 
1:250 Rabbit polyclonal 
Iba1 IHC Abcam (UK) 1:250 Goat polyclonal 
CD31 IHC Dianova (GER) 1:20 Rabbit polyclonal 
Streptavidin Cy3 IHC 
Southern Biotech 
(USA) 
1:400  
DAPI IHC Sigma (USA) 1:2500/1:1000  
Alexa Fluor®488 don-
key anti-rabbit 
IHC 
Thermo Fisher Scien-
tific (USA) 
1:250 Donkey 
donkey anti-rabbit IgG 
biotin 
IHC 
Jackson Immuno Re-
search (USA) 
1:400 Donkey 
Alexa Fluor®568 don-
key anti-goat IgG 
antibody 
IHC 
Thermo Fisher Scien-
tific (USA) 
1:250 Donkey 
 
2.2. Methods  
2.2.1. Animals and experimental procedures 
PI3Kγ knockout mice (PI3Kγ-/-) (Hirsch et al. 2000)and mice carrying a targeted mutation 
in the PI3Kγ gene causing loss of lipid kinase activity (PI3KγKD/KD) (Patrucco et al. 2004)were 
on the C57BL/6J background for > 10 generations. Age-matched C57BL/6 mice were used as 
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controls. The animals were maintained at 12 h light and dark cycles with free access to food 
and water. The animal procedures were performed according to the guidelines from Directive 
2010/63/EU of the European Parliament on the protection of animals used for scientific pur-
poses. Experiments were approved by the committee of the Thuringian State Government on 
Animal Research. 
Animals were divided into a cohort kept at neutral ambient temperature (29.5±0.5 °C) 
(Gordon et al. 1998) or another cohort kept at lowered ambient temperature (25.5±0.5 °C) dur-
ing the whole experimental period. After acclimatization for > 5 days mice received LPS (10 
mg/kg, intraperitoneal, from Escherichia coli serotype 055: B5, Sigma–Aldrich, St. Louis, USA, 
Lot #032M4082V) as a single intraperitoneal injection. Additionally, 500 µl saline was injected 
subcutaneously immediately after LPS administration as well as after 24 h to ensure appropri-
ate fluid resuscitation. Clinical status was estimated at baseline state and 24 h after LPS admin-
istration according to (Gonnert et al. 2011), which was based on the behavior and appearance 
of the mice. The classification of CSS grade was shown in Table 4. 
Table 4. Classification of CSS Grade (Gonnert et al. 2011) 
CSS 
level 
Quality Posture spontaneous activity Response to stimuli 
1 
No signs of 
illness 
Normal High activity quick, curious 
2 Low-grade 
Slightly hun-
ched 
Less active, interruption of 
activity 
Delayed, but adequate 
reaction 
3 Mid-grade Hunched 
Slow, sleepy, movements 
restricted 
Restricted and delayed 
reaction 
4 High-grade 
Severely hun-
ched 
lethargic, no movement No reaction 
 
As an in vitro correlate of hypothermia and neuroinflammation, primary microglia obtained 
from wild type, PI3Kγ-/- and PI3KγKD/KD were exposed to an incubation temperature (TInc) of 
33 °C and LPS (100 ng/ml). 
 
2.2.2. Telemetric assessment of body core temperature (Tc) and heart rate  
Tc and heart rate (HR) were assessed by telemetric monitoring of electrocardiography (ECG) 
and abdominal temperature. 
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Surgical procedure:  
Mice were anesthetized with 2.5% isoflurane in oxygen. A midline incision was made on 
the abdomen and the intraperitoneal cavity was gently opened. An implantable 1.6-g wireless 
radiofrequency transmitter (ETA-F10, Data Sciences International, St. Paul, MN) was inserted; 
the leads were transferred though the abdominal wall and the incision was closed by a surgical 
suture. The cathodal lead was looped forward subcutaneously to an area overlying the scapula 
and anchored in place with a permanent suture. The anodal lead was brought subcutaneously to 
rest near the heart apex. Thereafter skin incision was sutured. A warming light was used to 
maintain body temperature between 36 and 37 °C. Meloxicam was given for pain on the day of 
surgery and the following day. Experiments were initiated 10 days after recovery from surgical 
instrumentation. Animals were monitored continuously by telemetry by ECG as well as body 
temperature and motor activity recording.  
Data acquisition and processing:  
For simultaneous ECG and body temperature, analog signals were digitalized by the tele-
metric receiver (model RPC-1, Data Sciences International, St. Paul, MN) and transferred via 
DSI Data Exchange Matrix at a sampling rate of 2 kHz with 12-bit precision (acquisition soft-
ware: Ponemah Software 5.20) without a signal filter and stored on PC for off-line data analysis. 
Instantaneous heart rate was derived from the reciprocal RR interval time series. Therefore, the 
individual R-waves, with the R-wave peak as the trigger point, were sequentially recognized 
(ATISApro®, GJB Datentechnik GmbH, Langewiesen, Germany). Accurate R-wave peak de-
tection was verified by visual inspection. Temperature was continuously measured by the im-
planted transmitter and stored in parallel to the ECG signal.  
  
2.2.3. Measurement of blood-brain barrier permeability  
BBB disruption was analyzed by measurement of Evans blue (EB) extravasation into brain 
tissue as described previously (Comim et al. 2011; Frister et al. 2014). In brief, EB (4 ml/kg of 
a 2% solution in PBS) was injected through the tail vein 1 h prior killing. Deeply anaesthetized 
animals were transcardially perfused with ice-cold PBS (40 ml) 24 h after LPS administration. 
The brains were removed after blood removal, snap-frozen in liquid nitrogen and stored at -
80 °C. One hemisphere was homogenized in trichloroacetic acid (50%) and centrifuged (10,000 
rpm, 20 min, 4 °C). Supernatant was diluted in three volumes of ethanol. EB was quantified by 
fluorescence measurement (Tecan Infinite F200, excitation 620 nm, emission 670 nm) and 
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compared to a standard curve. EB concentrations are presented as µg of EB per µl of brain tis-
sue supernatant. 
 
2.2.4. Blood and brain tissue cytokine assessment  
The cytokines levels (TNFα, IL-6, MCP-1) in blood and brain tissue were determined using 
BD™ CBA Mouse Inflammation Kit (Dickinson and Company, San Jose, USA). Briefly, the 
brain tissue was harvested after rinsing with cold PBS, immediately put in liquid nitrogen and 
kept at -80 °C until processing. The brain tissue was then powdered, ice-cold diluted in PBS, 
homogenated, centrifuged at 1000 g for 10 min at 4 °C. Supernatant was immediately kept at -
80 °C until the measurement.  
Cytokines levels (TNFα, IL-6, MCP-1) in blood were also determined using BD™ CBA 
Mouse Inflammation Kit (Dickinson and Company, San Jose, USA). Briefly, the blood was 
collected in the heparinized needle via a direct puncture in the heart and immediately centri-
fuged at 1500 g for 10 min at 4 °C. Supernatant was immediately kept at -80 °C until the meas-
urement. 
 
2.2.5. Preparation of primary microglia  
The cell culture medium DMEM with thermally inactivated fetal calf serum (FCS, 10% 
v/v), Penicillin (100 units/ml), Streptomycin (100 µg/ml) and Amphotericin B (2,5 µg/ml) was 
used as the primary microglia culture medium. Primary microglial cells were isolated from the 
cerebral cortex of newborn C57BL/6J wild-type (WT), PI3Kγ-knockout (PI3Kγ-/-) and PI3Kγ 
kinase-dead (PI3KγKD/KD) mice (1-3 days after birth). The brains were collected and washed 
with PBS. The cortex hemispheres were separated after removing the meninges thoroughly, 
dissociated with dissociation solution (20 mM Hepes, 0.05% m/v Trypsin, 700 µM EDTA, 12 
µg/ml DNase in DMEM) and incubated for 20-30 min at 37 °C with gently mixing from time to 
time. After incubation, the cortex hemispheres were transferred to microglia culture medium 
(10% FCS, 1% penicillin, 1% amphotericin B) and triturated with a Pasteur-pipette. Then the 
cells were seeded into a T75 flask. The cells were co-cultivated with astrocytes for 14 days at 
37 °C and 5% CO2. The culture medium was changed once per week. After 14 days adherent 
microglia were separated from astrocytes by adding PBS/EDTA and careful shaking. Purity of 
isolated microglia was more than 95%. Homogeneity of preparation was confirmed by flow 
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cytometric detection of murine microglial marker F4/80 (data not shown). After harvesting, 
microglial cells were seeded in well plates. 
 
2.2.6. RNA Extraction and cDNA Synthesis 
For quantification of mRNA, cells were seeded into 6-well plates and incubated at 37 °C (5% 
CO2) overnight. Afterwards cells were disintegrated in Trizol reagent (Invitrogen Life Tech-
nologies; Darmstadt, Germany). Total RNA was extracted from Trizol as recommended by the 
manufacturer. To prevent contamination of mRNA preparation with chromosomal DNA, 
mRNA samples were treated with DNase. RNA amount and purity were determined by Nano- 
DropTM 1000 (Peqlab, Erlangen, Germany). For first strand cDNA synthesis, 1 µg total RNA 
was employed using the First Strand cDNA Synthesis Kit from Fermentas (St. Leon Rot, Ger-
many). Synthesis was performed by the protocol recommended by the manufacturer. 
 
2.2.7. Quantitative PCR 
Quantitative PCR (qPCR) was performed with Maxima SYBR Green/ ROX qPCR Master 
Mix Kit (Fermentas; St. Leon Rot, Germany) containing Maxima Hot Start Taq DNA polymer-
ase and appropriate primer pairs. The following primer pairs were used:  
MMP-2 forward: TGGCAGTGCAATACCTGAAC and MMP-2 reverse: CCGTACTT-
GCCATCCTTCTC,  
MMP-3 forward: GTACCAACCTATTCCTGGTTGC and MMP-3 reverse: CCAGAGAG-
TTAGATTTGGTGGG,  
MMP-9 forward: ACCACTAAAGGTCGCTCGGATGGTT, MMP-9 reverse: AG-
TACTGCTTGCCCAGGAAGACGAA,  
MMP-13 forward: GGGCTCTGAATGGTTATGACATTC, MMP-13 reverse: 
AGCGCTCAGTCTCTTCACCTCTT,  
GAPDH forward: CATGGCCTTCCGTGTTTCCTA and GAPDH reverse: 
CCTGCTTCACCACCTTCTTGAT.  
Relative mRNA expression was calculated in relation to mRNA levels of the housekeeping 
gene, GAPDH, according to 2-ΔΔCT method (Livak and Schmittgen 2001).  
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2.2.8. In Vitro Chemotaxis Assay (Transwell migration assay) 
To investigate the influence of lipid kinase dependent and -independent functions of PI3Kγ 
on microglial migration, transwell assays were performed. Cells were seeded in 6-well plates. 
After attachment, the cells were starved and incubated with serum-free medium overnight and 
then treated with LPS (100 ng/ml) for 24h. Following stimulation, 1 x 10
5
 cells were trans-
ferred in 300 µl serum-free medium into the upper chamber of a 12-well chemotaxis insert 
(ThinCertTM, 8 µm pores; Greiner-Bio-One GmbH, Frickenhausen Germany). The chamber 
was placed in 700 µl serum-free medium containing chemoattractant (C5a; 10 ng/ml) and incu-
bated at 37 °C (normal TInc) or at 33 °C (reduced TInc) with 5% CO2 for 2 h. Afterwards cells 
on the lower side of the insert membrane were fixed with 100% ice-cold methanol and stained 
with 0.5% crystal violet solution (in 25% methanol) for 10 min. Average count of migrated 
cells was estimated through consideration of five independent visual fields.  
 
2.2.9. In Vivo Microglial Migration Assay 
Experiments were performed on adult (10-14 weeks) wild type, PI3Kγ-/-, and PI3KγKD/KD 
mice (7 mice per group) kept during the whole experimental period at neutral Ta or reduced Ta, 
respectively. To investigate the effect of targeted PI3Kγ mutation on microglial migration, an 
in vivo wound healing experiment was performed. Mice were anesthetized by intraperitoneal 
injection of ketamine (100 mg/kg) and xylazine (16 mg/kg), and positioned in a stereotaxic 
apparatus (Stoelting, Wood Dale, IL, USA). Mice were then placed on a homeothermic heat 
blanket to maintain normal body temperature during surgery. The skull was exposed by a skin 
incision, and small burr holes were drilled through the skull. Using a micromanipulator focal 
stab, an injury was performed by gentle insertion of stainless steel pin (diameter 0.25 mm) into 
the parietal cortex at 3 mm below the dura mater (Schneble et al. 2017a; Seo et al. 2012). The 
pin was kept in place for two minutes and then removed. The burr holes were covered with 
bone wax, and the animals were returned to their cages. 12 h later, mice were deeply anesthe-
tized and perfused with 4% paraformaldehyde (PFA) in phosphate buffer by cardiac puncture 
via the left ventricle. Brains were removed immediately after fixation and postfixed for 5 h in 4% 
PFA at 4 °C. After cryoprotection in PBS containing 30% sucrose, brains were frozen in 
methylbutane at -30 °C and stored at -80 °C. 
Whole brains were cut by horizontal sections at 40 µm on a freezing microtome (Microm 
International GmbH, ThermoScientific, Germany). The slices were immunostained with anti-
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Iba1 antibody to visualize microglia. Sections were photographed with a digital fluorescence 
camera (Nikon DSQi2), mounted on the Nikon inverted research microscope ECLIPSE Ti 
(NIKON INSTRUMENTS EUROPE B.V., Amstelveen, The Netherlands). Quantitative meas-
urements (ImageJ software, National Institutes of Health, Bethesda, MD) blinded to the treat-
ment groups were used to count cell numbers per voxel and expressed in mm
3
. At the injured 
region, three voxels were predefined as follows: Voxel 1, a cylinder with a diameter of 400 µm, 
center lying in the middle of injury, and an altitude of 40 µm; Voxel 2, hollow cylinder, subse-
quently on Voxel 1, with an inner diameter of 400 µm, an outer diameter of 800 µm, and an 
altitude of 40 µm; Voxel 3, hollow cylinder, subsequently on Voxel 2, with an inner diameter 
of 800 µm, an outer diameter of 1200 µm, and an altitude of 40 µm. Number of Iba1-positive 
cells was counted in all three voxels. Migratory index was estimated as the ratio of cell number 
in Voxel 1 divided by the sum of cell number in Voxels 1, 2 and 3. 
 
2.2.10. In Vitro Phagocytosis Assay 
Efficiency of phagocytosis was investigated as previously described (Schneble et al. 2017a; 
Sun et al. 2008). Briefly, primary microglia cells obtained from wild type, PI3Kγ-/-, and 
PI3KγKD/KD mice were seeded into 12-well plates on coverslips and incubated (37 °C, 5% CO2) 
in microglia culture medium (10% FCS, 1% penicillin, 1% amphotericin B) and incubated at 
37 °C (5% CO2) for 24 h. Coverslips were coated 2 h by Poly-L-Lysine (25 µg/ml) at 37 °C 
before use. After attachment cells were starved for 24 h in DMEM without FCS. Cells were 
subsequently stimulated with LPS (100 ng/ml). Phagocytosis assay was performed by using 
fluoresceinisothiocyanate (FITC)-labeled Zymosan A S. cerevisiae BioParticles (9800 per µl) 
(# Z2841, Thermo Fisher Scientific, Waltham, USA). 7 µl of the suspended particles was added 
to the microglial cells and incubated 1 h at either 37 °C or 33 °C. After incubation the cells 
were fixed with 4% PFA, washed three times and stained with DAPI–solution for 5 min 
(1:1000 in PBS). Phagocytosed particles and cells of five independent visual fields were count-
ed under a fluorescence microscope. The result of the phagocytosis of primary microglia was 
calculated by determining the phagocytic index (the uptake rate of FITC-Zymosan particles per 
cell).  
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2.2.11. In Vivo Phagocytosis Assay 
Experiments were performed on adult (10-14 weeks) wild type, PI3Kγ-/-, and PI3KγKD/KD 
mice (7 mice per group) kept during the whole experimental period at neutral Ta or reduced Ta, 
respectively. To investigate the effect targeted PI3Kγ mutation on microglial phagocytosis 
FITC-labeled Zymosan particles (9800 per µl) were administered into the brain as described 
previously (Schmidt et al. 2013). Briefly, mice were anesthetized by intraperitoneal injection of 
ketamine (100 mg/kg) and xylazine (16 mg/kg), and positioned in a stereotaxic apparatus 
(Stoelting, Wood Dale, IL, USA). The skull was exposed by a skin incision, and small burr 
holes were drilled through the skull. Using a micromanipulator a cannula (diameter 0.24 mm) 
attached on a Hamilton microsyringe (10 µl) was stereotaxically placed into the parietal cortex 
on both sides (stereotaxic coordinates were AP, -2.0 mm; L, ±0.5 mm; and V, -2.5 mm, respec-
tively (Paxinos and Franklin 2001)). Subsequently, 4 µl of FITC-labeled Zymosan particles 
suspended in artificial cerebrospinal fluid were infused within 120 seconds. The cannula re-
mained in place for 5 minutes before removal. Twenty-four hours later mice were deeply anes-
thetized and perfused with 4% PFA in phosphate buffer by cardiac puncture via the left ventri-
cle. Brains were removed immediately after fixation and post-fixed for 5 h in 4% PFA at 4 °C. 
After cryoprotection in PBS containing 30% sucrose, brains were frozen in methylbutane at -
30 °C and stored at -80 °C. Whole brains were cut by coronal sections at 40 µm on a freezing 
microtome (Microm International GmbH, Thermo Scientific, Germany). The slices were im-
munostained with anti-Iba1 antibody to visualize microglia. A voxel with an edge length of 400 
µm, and an altitude of 40 µm were predefined as region of interest. Z-stack imaging was per-
formed with a 20x objective using a digital fluorescence camera (Nikon DS-Qi2), mounted on 
the Nikon inverted research microscope ECLIPSE Ti (NIKON INSTRUMENTS EUROPE 
B.V., Amstelveen, The Netherlands). Quantitative measurements (ImageJ software, National 
Institutes of Health, Bethesda, MD) blinded to the treatment groups were used to count the per-
centage number of Iba-1 positive cells per mm
3
 containing Zymosan particles. 
 
2.2.12. Histopathology and immunohistochemistry  
For determination of microglial activation, PMN homing, MMP-9 expression and terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positivity brains were fixated 
in situ by transcardial perfusion with 4% PFA after rinsing with PBS. Afterwards, they were 
immediately removed after fixation, post-fixated in 4% PFA at 4 °C for 1 day, embedded in 
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paraffin and cut into 6-μm-thick sections. After deparaffinization, the sections were heated with 
citrate buffer (0.01 M, pH6.0) in the microwave (630 W, 11min) for antigen removal and the 
nonspecific binding sites were blocked with blocking solution (5% NDS, 1% BSA-c, PBST). 
Then the slide-mounted tissue sections were incubated with the desired primary antibody in 
antibody incubation solution (5% NDS, 1% BSA-c, PBST) at 4 °C overnight, followed by an 
incubation with the associated secondary antibody at 4 °C for 1 h. Negative control sections 
were incubated with goat serum in absence of the primary antibody. The following primary 
antibodies were used: goat polyclonal anti-Iba-1 (1:250) antibody (Abcam, Cambridge, UK) for 
Iba1 staining, rabbit polyclonal anti-MMP-9 (1:150) antibody (Cell Signaling Technology, 
Danvers, USA) for MMP-9 and rabbit anti-mouse PMN (ACCURATE CHEMICAL & SCI-
ENTIFIC CO, USA) for neutrophils staining. For visualization, the secondary fluorescent goat 
anti-mouse isotype-specific antibody Alexa Fluor® 488 (Molecular Probes, Inc., Eugene, USA), 
donkey anti-goat IgG antibody Alexa Fluor®568 (Thermo Fisher Scientific, Waltham, USA) 
were used. Method for TUNEL staining was described elsewhere (Brodhun et al. 2001). Briefly, 
sections were deparaffinized and prepared for TUNEL-staining. Fragmented DNA was detect-
ed in situ by the TUNEL method using a commercially available kit according to the manufac-
turer’s protocol (In Situ Cell Death Detection Kit, POD; Roche, Germany). Deparaffinized sec-
tions were pretreated with 20 mg/ml proteinase K and washed in PBS prior to TUNEL staining. 
TUNEL staining was performed by incubation with fluorescein-conjugated digoxigenin-UTP 
and terminal deoxynucleotidyltransferase at 37 °C for 1 h. DNA fragmentation was visualized 
using converter-alkaline phosphatase, NBT/BCIP and counterstaining with Kernechtrot.  
Assessment of microglial activation after LPS-induced SIRS were performed by use of 
morphological criteria, as previously described (Kettenmann et al. 2011; Zhang et al. 2008).  
Stained brain sections were visualized by fluorescence imaging. Iba-1 positive cells, which 
had a clear nucleus, were included in the analysis. Three randomly sampled areas from frontal 
cortex, hippocampus and thalamus were examined. The percentage of a particular cell type 
(ramified or polarized, Fig.3) was obtained by calculating the ratio of the cell number of this 
type to the total number of microglial cells examined per section. 
Cell counting as well as estimation of migration and phagocytic index were performed 
blinded for genotype and treatment. In each case evaluation was performed on three different 
slices obtained from frontal cortex, thalamus and hippocampus, each. Five separate fields of 
vision were counted with at least 100 cells each. 
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Figure 3. Morphology of surveillant (“resting”) and activated microglia.  
Iba-1 positive cells were assessed as brain microglial cells. They were classified as ramified (A), amoeboid 
(B), unipolar (C) and bipolar (D). Ramified microglial cells are defined by thin, slender, radially projecting 
processes with well-developed ramifications. Amoeboid microglial cells are defined as having large soma, 
and short, thick and radially projecting processes. Unipolar and bipolar microglial cells were defined as hav-
ing one or two thick process with well-developed ramifications. 
 
2.2.13. Cell metabolism measurement 
OCR (oxygen consumption rate) and ECAR (extracellular acidification rate), as indicators 
of cellular oxidative phosphorylation and glycolysis, respectively, were monitored consecutive-
ly with a Sea-horse Bioscience extracellular flux analyzer (XF96, Seahorse Bioscience) as de-
scribed previously (Gerencser et al. 2009). Approximately 20 x 10³ cells were seeded on 96-
well Seahorse XF96 microplates. Cells were starved and treated with LPS (100 ng/ml) for 24h 
at different temperatures (33 °C and 37 °C). Before the experiment, cell supernatants were re-
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placed by Agilent Seahorse XF Assay Medium, pH 7.4, supplemented with 10 mM D-glucose 
(Sigma Aldrich, Germany) and 1 mM sodium pyruvate (Thermo Fisher Scientific, Germany). 
Cells were then cultured for one hour in a CO2-free incubator at 37 or 33 °C. OCR and ECAR 
were monitored at basal conditions as pmoles/min and mpH/min respectively, in cycles of 3 
min mix and 3 min measure at 37 or 33 °C in six replicates per condition. All values were nor-
malized to exact cell numbers, which was measured by high-content microscopy. For that pur-
pose, cell supernatants were removed from the 96-well Seahorse XF96 microplate and cells 
were 10 min fixed with 100% methanol at room temperature. Cells were then washed once with 
PBS and incubated for 10 min with 1 μg/ml DAPI at room temperature. After two more wash-
ing steps with PBS, cell nuclei were counted on an ImageXpress Micro confocal high-content 
imaging system (Molecular Devices). 
 
2.2.14. Statistics  
The statistical analysis was performed using SigmaPlot Software (Sigma-Plot Software, 
San Jose, USA). All data are presented as boxplots illustrating medians within boxes from first 
quartile (25th percentile) to the third quartile (75th percentile) and whiskers ranging from the 
10th to the 90th percentiles (extreme values are marked outside). Numbers of animals are given 
in figure legends for each group and time point. Comparisons between groups were made with 
one-way or two-way analysis of variance, if appropriate. In case of repeated measurements, 
one-way and two-way analysis of variance with repeated measures was used, if appropriate. 
Post hoc comparisons were made with the Holm-Sidak test or t-tests with Bonferroni’s correc-
tion for adjustments of multiple comparisons. Data not following normal distribution was tested 
with Kruskal-Wallis test followed by Dunn’s multiple comparisons test. 
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3. Results 
3.1. Impact of ambient temperature on degree of SIRS and SIRS-induced BBB disturbance 
Intraperitoneal LPS administration (10 mg/kg) induced a robust and similarly distinct SIRS in 
mice kept under neutral as well as reduced Ta and mainly independent from genetic status, as re-
vealed by corresponding cytokine release in blood plasma and brain tissue (Tab. 5). However, re-
duced Ta induced a moderately worsened sickness state in PI3Kγ-deficient mice (Tab. 6). 
 
 
Figure 4. Influence of Ta on heart rate and hypothermia. 
Enhanced heart rate and augmented hypothermia in mice kept under reduced ambient temperature (Ta) after LPS-
induced SIRS response compared with mice kept under neutral Ta irrespective of the genotype (wild-type mice, 
open boxplots, PI3Kγ-deficient mice (PI3Kγ
-/-
) filled boxplots, PI3Kγ-kinase-dead mice (PI3Kγ
KD/KD
) hatched 
boxplots).Values are presented as boxplots illustrating medians within boxes from first quartile to the third quar-
tile, whiskers ranging from the 10th to the 90th percentiles (neutral Ta groups: wild type mice n=9, PI3Kγ
-/- 
n=10, 
PI3Kγ
KD/KD
, n=8; reduced Ta groups: wild type mice n=12, PI3Kγ
-/- 
n=10, PI3Kγ
KD/KD
 n=9). *
 †
 p < 0.05, * signifi-
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cant difference between baseline and LPS stimulation within each Ta state, 
†
 significant differences versus mice 
kept under neutral Ta (two-way repeated measures ANOVA, followed by Holm-Sidak test for post hoc multiple 
comparisons were performed). 
 
Telemetric Tc monitoring revealed that under baseline conditions all mice kept under neutral as 
well as reduced Ta showed no differences in body temperature. However, reduced Ta was obviously 
accompanied by an enhanced sympathetic tone to the heart already under baseline condition, indi-
cated by a markedly increased HR regardless of the genotype (Fig. 4).  
 
Figure 5. Influence of Ta on BBB integrity. 
Enhanced BBB leakage by PI3Kγ-deficiency at reduced Ta at LPS induced SIRS. (A) Mild disturbance of BBB 
integrity in PI3Kγ mutant mice kept under neutral Ta. LPS-induces SIRS elicit small increase of BBB leakage in 
wild type mice (Wt, open boxplots). (B) Reduced Ta was accompanied by enhanced Evans blue (EB) extravasa-
tion into brain tissue indicating degree of BBB leakage in PI3Kγ-deficient (PI3Kγ
-/-
) mice (filled columns) in 
comparison with Wt and kinase-dead (PI3Kγ
KD/KD
, hatched boxplots) mice. Values are presented as boxplots illus-
trating medians within boxes from first quartile (25th percentile) to the third quartile (75th percentile) and whisk-
ers ranging from minimum to maximum, n=10 per group and time point. *
 † §
 p < 0.05, * significant differences 
versus baseline conditions within the same genotype, 
† 
 significant differences versus neutral Ta within the same 
genotype, 
§
 significant differences versus Wt mice within the same Ta condition (Two-way ANOVA and one-way 
ANOVA, followed by Holm-Sidak test for post hoc multiple comparisons was performed for comparison between 
respected groups, t-test was used for comparisons between states within same groups with Bonferroni’s correction 
for adjustments of multiple comparisons)
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Table 5. Cytokine content in blood plasma and brain tissue  
Cytokine content Baseline LPS 3h 
 
LPS 24h 
Blood plasma 
     TNF (ngml
-1
)      
neutral Ta Wt 4.9 (4.8; 5.4) 2329 (2081; 2755)* 5.7 (5.7; 7.9) 
 
PI3Kγ-/- 4.1 (4.1; 4.6) 2951 (2741; 3066)* 6.1 (4.7; 7.7) 
 
PI3KγKD/KD 3.0 (2.8; 4.5) 1322 (1182; 1368)* 3.5 (3.6; 4.0) 
reduced Ta Wt 6.3 (5.4; 6.5) 1892 (1767; 2105)* 3.4 (3.2; 5.1) 
 
PI3Kγ-/- 4.7 (4.6; 5.6) 1580 (1530; 1597)* 5.9 (5.5; 6.0) 
 
PI3KγKD/KD 4.8 (3.7; 4.9) 1190 (1169; 1512)*§ 6.3 (5.3; 8.5) 
Il6 (ngml
-1
) 
     neutral Ta Wt 4.2 (3.8; 4.6) 101277 (94178; 134250)* 494 (469; 529)* 
 
PI3Kγ-/- 3.4 (3.3; 3.4) 77147 (69520; 92818)*§ 451 (412; 549)* 
 
PI3KγKD/KD 3.0 (2.9; 3.1) 37417 (32741; 45597*§ 296 (281; 401)* 
reduced Ta Wt 6.0 (4.9; 10.8) 81446 (73249; 105982)* 444 (381; 541)* 
 
PI3Kγ-/- 3.5 (3.5; 8.6) 68946 (60700; 71937)* 404 (368; 514)* 
 
PI3KγKD/KD 3.1 (3.0; 3.3) 55578 (48955; 71880)*§ 207 (178; 249)* 
MCP-1 (ngml
-1
) 
     neutral Ta Wt 14.1 (13.7; 24.1) 77811 (69094; 90783)* 6468 (6427; 6493)* 
 
PI3Kγ-/- 7.7 (6.8; 7.9) 71915 (69727; 79884)* 6160 (5048; 6176)* 
 
PI3KγKD/KD 6.8 (3.8; 7.9) 49375 (41716; 59061)*†§ 3994 (3407; 5077)* 
reduced Ta Wt 12.4 (9.8; 13.7) 49757 (44674; 62181)*
†
 1733 (1564; 2236)* 
 
PI3Kγ-/- 3.8 (1.9; 6.0) 41911 (39677; 43170)* 3250 (2483; 3456)* 
 
PI3KγKD/KD 8.1 (5.5; 8.5) 38229 (36030; 48311)* 5940 (5879; 6727)* 
Brain tissue  
     TNF (ngg
-1
) 
     neutral Ta Wt 2.4 (1.7; 2.4) 10.5 (8.5; 11.0)* 2.5 (2.5; 2.7) 
 
PI3Kγ-/- 2.8 (2.6; 3.3) 11.4 (10.4; 12.5)*§ 3.0 (1.8; 4.3) 
 
PI3KγKD/KD 2.0 (1.8; 2.9) 8.3 (7.8; 8.9)*§ 7.5 (4.8; 9.9) 
reduced Ta Wt 2.4 (1.8; 2.5) 26.3 (25.0; 27.6)*
†
 2.7 (2.6; 4.0) 
 
PI3Kγ-/- 2.5 (2.1; 2.6) 12.0 (9.5; 28.1)*†§ 4.9 (4.3; 7.7) 
 
PI3KγKD/KD 2.7 (1.7; 2.9) 10.6 (7.9; 11.8)*
§
 9.7 (6.0; 14.6) 
Il6 (ngg
-1
) 
     neutral Ta Wt 2.8 (2.8; 3.0) 471 (427; 602)* 9.8 (9.3; 10.2)* 
 
PI3Kγ-/- 3.5 (3.3; 3.7) 367 (356; 378)*§ 10.9 (9.7; 12.6)* 
 
PI3KγKD/KD 2.6 (2.6; 2.9) 226 (218; 233)*
§
 17.4 (15.8; 21.8)* 
reduced Ta Wt 3.4 (2.8; 3.4) 406 (386; 426)*
†
 20.5 (20.5; 21.7)* 
 
PI3Kγ-/- 1.9 (1.9; 2.7) 270 (266; 408)* 14.2 (11.8; 15.4)* 
 
PI3KγKD/KD 3.4 (3.0; 3.4) 153 (143; 163)*†§ 21.5 (19.5; 26.5)* 
MCP-1 (ngg
-1
) 
     neutral Ta Wt 17.7 (15.7; 22.0) 1038 (1001; 1179)* 333 (296; 336)* 
 
PI3Kγ-/- 13.2 (12.1; 17.9) 1102 (1095; 1110)* 228 (222; 266)* 
 
PI3KγKD/KD 24.2( 20.6; 26.9) 1049 (986; 1112)* 468 (354; 483)* 
reduced Ta Wt 12.8 (12.4; 14.6) 1068 (1015; 1122)* 317 (266; 383)* 
 
PI3Kγ-/- 17.1 (12.4; 17.0) 908 (877; 1040)* 368 (288; 408)* 
 
PI3KγKD/KD 14.9 (12.4; 20.7) 637 (616; 856)*†§ 247 (243;327)* 
 
(Values are given as medians as well as the first quartile and third quartile in parenthesis, *
 † §
 p < 0.05, * 
significant differences versus baseline conditions within the same genotype, 
† 
significant differences versus 
neutral Ta within the same genotype, 
§
 significant differences versus wild type (Wt) mice within the same Ta 
condition). 
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Figure 5 reveals a small BBB breakdown 24 hours after LPS administration in PI3Kγ-
deficient and PI3Kγ-kinase-dead mice, when housed under neutral Ta. Additional LPS-induced 
SIRS provoked an increase of BBB leakage in wild type mice, whereas PI3Kγ-deficient mice 
exhibited a small but significantly enhanced BBB disturbance compared with wild type mice. 
In contrast, housing under reduced Ta induced BBB breakdown in wild type mice at a similar 
degree as ascertained in the mutant mice (Fig 5B). Additional LPS-induced SIRS provoked a 
substantially enhanced BBB breakdown, which was most pronounced in PI3Kγ-deficient mice. 
Of note, lipid kinase-dead mutant mice display similar degree of BBB breakdown as wild type 
mice indicating a causal impact of lipid kinase independent PI3Kγ signaling on the verified 
phenotypes.  
Table 6. Clinical severity score (according to Gonnert et al 2011). 
 Baseline 24h-LPS 
Neutral Ta   
Wt 1.0 (1.0; 1.0) 1.5 (1.0; 2.0)* 
PI3Kγ-/- 1.0 (1.0; 1.0) 2.0 (1.5; 2.0)* 
PI3KγKD/KD 1.0 (1.0; 1.0) 1.0 (1.0; 2.0)* 
 
  
Reduced Ta 
  Wt 1.0 (1.0; 1.0) 2.0 (1.5; 2.0)* 
PI3Kγ-/- 1.0 (1.0; 1.0) 2.5 (2.0; 3.0)*
†§ 
PI3KγKD/KD 1.0 (1.0; 1.0) 2.0 (2.0; 2.0)*
 † 
 
(Values are given as medians as well as the first quartile and third quartile in parenthesis, n=4-6 animals at 
each group and experimental state. *
 §
 †p < 0.05, * significant difference between baseline and LPS-
stimulated state within each group, 
§
 significant difference versus wild type (Wt) mice kept under same am-
bient temperature, †significant differences versus mice kept under neutral ambient temperature). 
 
3.2. Impact of Ta dependent BBB disturbance on degree of microglial activation, MMP 
expression, apoptosis, and PMN invasion  
To verify consequences of LPS-induced BBB disturbance, extent of neuroinflammation was 
assessed by different approaches. First we quantified the number of activated microglial cells 
assessed by shape characteristics (Kettenmann et al. 2011; Zhang et al. 2008). As shown in Fig. 
6, a marked increase in microglial cell number with altered, mainly polarized shape occurred. 
Analysis of regional distribution revealed similarity in extent of microglial cell activation in 
brain cortex, hippocampus and thalamus (Tab. 7) suggesting a diffuse microglial activation due 
to LPS-induced SIRS. Though, a significant genotype related effect could not be emerged. In 
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contrast, MMP expression in brain tissue obtained 24 hours after LPS injection displayed sig-
nificant PI3Kγ dependency.  
 
  
 
 
 
Figure 6. Influence of Ta on microglial cell acti-
vation in mice brain. 
 
Marked increase of microglial cell activation by 
LPS-induced SIRS in mice kept under neutral Ta 
(A) and reduced Ta (B), C: representative images of 
microglial activation. Brain microglial cells were 
classified as ramified (a), amoeboid (b), unipolar 
(c) and bipolar (d). (Details see 2.2.12). Values are 
presented as boxplots illustrating medians within 
boxes from first quartile to the third quartile and 
whiskers ranging from the 10th to the 90th percen-
tiles (A, B: n=4-6, at each group and experimental 
state. *
 § †
 p < 0.05, * significant difference between 
baseline within each group, 
§
 significant differences 
versus wild type mice kept under same Ta, 
†
 signifi-
cant differences versus mice kept under neutral Ta 
at the same experimental state, two-way ANOVA, 
followed by Holm-Sidak test for post hoc multiple 
comparisons, each). 
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Table 7. Quantitative analysis of cell density of activated microglia (assessed by cell shape characteristics) in different brain structures 
Groups Cortex Hippocampus Thalamus 
 Baseline 24h-LPS Baseline 24h-LPS Baseline 24h-LPS 
Neutral Ta       
Wt 0.04 (0.03, 0.04) 0.28 (0.2, 0.36) * 0.06 (0.05, 0.07) 0.27 (0.22, 0.33) * 0.09 (0.05, 0.09) 0.3 (0.28, 0.31) * 
PI3Kγ-/- 0.05 (0.02, 0.08) 0.4 (0.28, 0.51) * 0.05 (0.03, 0.09) 0.5 (0.4, 0.56) *
§ 0.15 (0.12, 0.18) 0.6 (0.58, 0.65)  *§ 
PI3KγKD/KD 0.04 (0.03, 0.06) 0.32 (0.3, 0.35) * 0.06 (0.03, 0.12) 0.42 (0.39, 0.44) * 0.12 (0.09, 0.16) 0.41 (0.36, 0.47) * 
 
      
Reduced Ta 
      Wt 0.03 (0.02, 0.09) 0.39 (0.3, 0.43) * 0.04 (0.02, 0.09) 0.38 (0.33, 0.38) * 0.13 (0.05, 0.19) 0.46 (0.44, 0.48) *†  
PI3Kγ-/- 0.05 (0.04, 0.06) 0.51 (0.38, 0.38) * 0.06 (0.05, 0.08) 0.55 (0.5, 0.5) *
§ 0.09 (0.08, 0.11) 0.61 (0.53, 0.63) * 
PI3KγKD/KD 0.06 (0.04, 0.08) 0.33 (0.28, 0.34) * 0.07 (0.06, 0.09) 0.35 (0.28, 0.42) * 0.1 (0.07, 0.1) 0.43 (0.39, 0.43) * 
 
(Values are given as medians as well as the first quartile and third quartile in parenthesis, n=4-6 animals at each group and experimental state. *
 §
 †p < 0.05, * significant differ-
ence between baseline and LPS-stimulated state within each group, 
§
 significant difference versus wild type (Wt) mice kept under same ambient temperature, †significant differ-
ences versus mice kept under neutral ambient temperature). 
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There was an enhanced RNA expression in brains obtained from PI3Kγ-deficient mice 
kept under reduced Ta in all MMPs under consideration compared to mice kept under neutral 
Ta (Fig. 7). Furthermore, there was an increased mRNA expression in brains derived from 
PI3Kγ–deficient mice kept under reduced Ta compared with wild type mice kept under same 
housing conditions. In contrast, PI3KγKD/KD mice showed a similar response as wild type mice 
suggesting a lipid kinase independent mode of action. Increased cerebral MMP expression 
appeared apparently as a result of reinforced microglial activation in PI3Kγ-/- mice kept under 
reduced Ta shown by an increased number of MMP-9 positive cells co-expressed in Iba-1 
positive cells in these brains (Fig. 8). Analysis of regional distribution revealed similarity in 
the extent of microglial MMP-9 expression in brain cortex, hippocampus and thalamus (Tab. 
4). 
 
Figure 7. Influence of Ta on MMPs mRNA expression in mice brain. 
Increased LPS-induced mRNA expression of MMP-2, MMP-3, MMP-9, and MMP-13 appeared mainly in 
brains obtained from PI3Kγ-deficient mice kept under reduced Ta. Values are presented as boxplots illus-
trating medians within boxes from first quartile to the third quartile and whiskers ranging from the 10th to 
the 90th percentiles (A-D n=5 at each group and experimental state. 
§ †
 p < 0.05, 
§
 significant differences 
versus wild type mice kept under same Ta, 
†
 significant differences versus mice kept under neutral Ta at the 
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same experimental state, two-way ANOVA, followed by Holm-Sidak test for post hoc multiple compari-
sons, each). 
 
Figure 8. Influence of Ta on microglial MMP-9 expression. 
Increased number of MMP-9 positive microglial cells in brains obtained from PI3Kγ
-/-
 and PI3Kγ
KD/KD
 
mice kept under reduced Ta (B) compared to mice kept under neutral Ta (A) 24h after LPS administration. 
C: representative images of microglial activation (see next page). Values are presented as boxplots illustrat-
ing medians within boxes from first quartile to the third quartile and whiskers ranging from the 10th to the 
90th percentiles (lower panel: neutral Ta, upper panel: reduced Ta, n=4 at each group and experimental 
state. * 
§ †
 p < 0.05, * significant differences versus baseline at the same genotype and experimental state, 
§
 
significant differences versus wild type mice kept under same Ta, 
†
 significant differences versus mice kept 
under neutral Ta at the same experimental state, two-way ANOVA, followed by Holm-Sidak test for post 
hoc multiple comparisons, each).  
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To examine a possible Ta-dependent impact of LPS-induced BBB leakage on structural in-
tegrity of brain tissue, we quantified the extent of apoptosis in brain slices derived from wild 
type, PI3Kγ-/-, and PI3KγKD/KD mice kept under neutral and reduced Ta. Already under base-
line conditions the rate of apoptotic cells was significantly increased in brains of PI3Kγ-/- mice 
kept under reduced Ta compared with those kept at neutral Ta. LPS-induced SIRS exhibited 
always an increased number of apoptotic cells, which was most pronounced in PI3Kγ-/- mice 
kept under reduced Ta (Fig. 9). 
 
Figure 9. Influence of Ta on apoptosis. 
Increased number of apoptotic cells in brains obtained from PI3Kγ
-/-
 and PI3Kγ
KD/KD
 mice kept under re-
duced Ta (B) compared to mice kept under neutral Ta (A) 24h after LPS administration. C: representative 
images. Values are presented as boxplots illustrating medians within boxes from first quartile to the third 
quartile and whiskers ranging from the 10th to the 90th percentiles (lower panel: neutral Ta, upper panel: 
reduced Ta, n=4 at each group and experimental state. * 
§ †
 p < 0.05, * significant differences versus base-
line at the same genotype and experimental state, 
§
 significant differences versus wild type mice kept under 
same Ta, 
†
 significant differences versus mice kept under neutral Ta at the same experimental state, two-way 
ANOVA, followed by Holm-Sidak test for post hoc multiple comparisons, each).  
 
Regional comparison revealed that number of TUNEL-positive cells were markedly high-
er in the hippocampus, compared to cortex and thalamus, respectively (Tab. 8). 
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To assess a contribution of blood-born immune cells on pathogenesis of SIRS-induced 
SAE, the extent of invading PMN was gathered. Whereas under baseline conditions merely 
scattered PMN were encountered and neither Ta nor genotype-related effects has been ascer-
tained, LPS-induced SIRS was accompanied by a marked increase of invading PMN into the 
brain tissue. We found a distinct Ta dependent effect in PI3Kγ-deficient mice because of an 
enhanced PMN homing into brain tissue in mice kept under reduced Ta (Fig. 10). However, a 
regional accentuation has not been verified (Tab. 8). 
 
Figure 10. Influence of Ta on PMN invading. 
Increased number of invading PMN in brains obtained from mice kept under reduced Ta (B) compared to 
mice kept under neutral Ta (A) 24h after LPS administration. This was more pronounced in brains obtained 
from PI3Kγ
-/-
 mice. C: representative images. Values are presented as boxplots illustrating medians within 
boxes from first quartile to the third quartile and whiskers ranging from the 10th to the 90th percentiles 
(lower panel: neutral Ta, upper panel: reduced Ta, n=4 at each group and experimental state. * 
§ †
 p < 0.05, * 
significant differences versus baseline at the same genotype and experimental state, 
§
 significant differences 
versus wild type mice kept under same Ta, 
†
 significant differences versus mice kept under neutral Ta at the 
same experimental state, two-way ANOVA, followed by Holm–Sidak test for post hoc multiple compari-
sons, each).  
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3.3. Impact of Ta / TInc on microglial migration and phagocytosis  
The ability to migrate toward different chemotactic stimuli including those released by 
brain injuries is one important property of microglial cells, which is essential for biological 
functions. Previous own studies revealed a dependency of lipid kinase-related PI3Kγ signal-
ing on directed motility of microglial cells owing to inflammatory stimulation (Schneble et al. 
2017b). Herein we addressed the question if PI3Kγ dependent migration of this cell type is a 
result of different ambient temperature or its in vitro surrogate, e.g. varied temperatures of 
incubation.  
First, the in vitro cell motility was quantified toward migration to C5a added to bottom 
well of the transwell assay together with stimulation with LPS. C5a acts as inflammatory pep-
tide resulting in stimulation of microglial migration toward this chemo attractant. As demon-
strated in Figure 11, PI3Kγ-deficiency as well as targeted knockout of the lipid kinase activity 
of PI3Kγ caused a markedly reduced migratory capacity by about 50% compared with cells 
derived from wild type mice. A moderately reduced TInc provoked a further reduction in di-
rected motility of primary microglial cell, whereas the PI3Kγ related migratory alteration re-
mained preserved. 
To assess the effect of PI3Kγ-deficiency on directed cell motility in vivo, a wound healing 
assay using focal stab-injury (Schneble et al. 2017a) was carried out (Fig. 11B). Whereas the 
basal number of microglial cells was similar in wild type, PI3Kγ deficient and -kinase dead 
brains (Tab. 9), migration of microglia in direction of the focal stab injury was clearly reduced 
in brains from PI3Kγ mutants as indicated by reduced microglial cell numbers in the outer 
regions of interest (Areas 2 and 3; 200 to 400 and 400 to 600 µm from the place of injury) of 
the injury site, which was markedly reduced in mice kept at reduced Ta. Taken together, data 
indicate an inhibitory role of reduced Ta for the directional migration/chemotaxis of micro-
glia. 
The role of modified ambient temperature for phagocytosis, as another essential function 
of microglia, was also analyzed. First, efficiency of phagocytosis was quantified by in vitro 
incubation of microglia with FITC-labeled Zymosan particles and subsequent counting of 
incorporated particles inside the microglial cells. PI3Kγ deficiency caused a distinct decrease 
of phagocytosis of microglial cells under normal TInc (Fig. 12A). Under reduced TInc quite 
similar effects has been ascertain. In vivo analysis of phagocytosis was performed by intracer-
ebral administration of Zymosan particles. Counting the number of cells with phagocytosed 
particles revealed under neutral Ta a reduction of microglial phagocytic activity in brains de-
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rived from PI3Kγ-/- mice. Reduced Ta caused a distinct inhibition of phagocytic activity which 
was more pronounced in PI3Kγ-deficient mice (Fig. 12B). 
 
Figure 11. PI3Kγ-dependent suppression of 
microglial motility.  
Lipid kinase dependent reduction of migratory 
activity induced by chemoattractant- stimulated 
migration of primary microglial cells (A) and 
brain injury (B). Reduced ambient temperature 
as well as reduced temperature of incubation 
(TInc=33 °C) led to a further decline of micro-
glial motility. C: representative images. Values 
are presented as boxplots illustrating medians 
within boxes from first quartile to the third 
quartile and whiskers ranging from the 10th to 
the 90th percentiles (A & B: n=5 at each group 
and experimental state. 
§ †
 p < 0.05, 
§
 significant 
differences versus cells derived from wild type 
mice kept under same Ta or TInc, 
†
 significant 
differences versus cells derived from mice kept 
under normal Ta or TInc at the same experi-
mental state and genotype, two-way ANOVA, 
followed by Holm-Sidak test for post hoc mul-
tiple comparisons, each). 
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Table 8. Regional distribution of MMP-9 positive cells, TUNEL positive cells and invading polymorphonuclear leukocytes (PMN) 
 
(Values are given as medians as well as the first quartile and third quartile in parenthesis. n=4 at each group and experimental state.*
 † § $
 p < 0.05, * significant differences versus 
baseline at the same genotype and experimental state, 
†
 significant differences versus mice kept under neutral Ta at the same experimental state, 
§
 significant differences versus 
wild type mice kept under same Ta, 
$
 significant differences versus cortex & thalamus, two-way ANOVA, followed by Holm-Sidak test for post hoc multiple comparisons, each).
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Table 9. Number of microglial cells in brain cortex  
 Baseline 
Neutral Ta  
Wt 4483 (4447; 4554) 
PI3Kγ-/- 4132 (4099; 4371) 
PI3KγKD/KD 4536 (4362; 4653) 
 
 
Reduced Ta 
 Wt 4464 (4259; 4582) 
PI3Kγ-/- 4303 (4160; 4664) 
PI3KγKD/KD 4546 (4399; 4615) 
 
(Values are given as medians as well as the first quartile and third quartile in parenthesis. n=7-8 at each 
group and experimental state, one-way ANOVA). 
Therefore, reduced Ta enhanced the PI3Kγ dependent influence on microglial migration 
and phagocytosis. 
3.4. Effects of TInc on cellular energetics of microglia 
We evaluated the effects of normal and reduced TInc on the cellular energetics of microglia 
following 24 h of LPS treatment using the Seahorse XF96 Analyzer. Estimation of mitochon-
drial oxygen consumption rate (OCR) under baseline conditions revealed a small but signifi-
cant OCR increase in PI3Kγ-/- cells when incubated under normal conditions, whereas micro-
glia derived from PI3KγKD/KD mice exhibited a reduced respiration rate under normal and re-
duced TInc (Fig. 11). LPS stimulation provoked under normal incubation temperature a reduc-
tion of OCR in all genotypes under consideration, whereas just wild type cells showed the 
same behavior under reduced TInc. Furthermore, microglial cells derived from PI3Kγ
-/-
 as well 
as PI3KγKD/KD mice, indicative for inhibition of the lipid kinase/AKT pathway, exhibited a 
reduced glycolytic activity (Fig. 13). Moreover, a reduced glycolytic activity occurred in mi-
croglial cells after LPS stimulation, when incubated at 33 °C. 
These data indicate a rather minor impact of LPS stimulation on the cellular energetics of 
primary microglial cells. 
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Figure 12. PI3Kγ-kinase activity independent suppression of phagocytic activity.  
Under in vivo conditions, PI3Kγ lipid kinase independent reduction of phagocytosis induced a reduced 
phagocytic activity in mice kept under reduced Ta (B). C: Representative images from in vitro studies, D: 
representative images from in vivo studies. Values are presented as boxplots illustrating medians within 
boxes from first quartile to the third quartile and whiskers ranging from the 10th to the 90th percentiles (A: 
n=5, B: n=7 at each group and experimental state. 
§ †
 p < 0.05, 
§
 significant differences versus cells derived 
from wild type mice kept under same Ta or TInc, 
†
 significant differences versus cells derived from mice 
kept under normal Ta or TInc at the same experimental state and genotype, two-way ANOVA, followed by 
Holm–Sidak test for post hoc multiple comparisons, each).  
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Figure 13. Effect of PI3Kγ on regulation of cellular energetics in primary microglia.  
(A: TInc=37 °C, B TInc=33 °C; n=4 at each group and experimental state. OCR, basal oxygen consumption 
rate; ECAR, extracellular acidification rate). Values are presented as boxplots illustrating medians within 
boxes from first quartile to the third quartile and whiskers ranging from the 10th to the 90th percentiles.
 
* 
§ 
† $
 p < 0.05, 
§
 significant differences versus cells derived from wild type mice kept under same Ta, 
†
 signifi-
cant differences versus cells derived from mice kept under normal Ta at the same experimental state and 
genotype, 
$
 compared to PI3Kγ
-/-
 at the same experimental state, two-way ANOVA, followed by Holm-
Sidak test for post hoc multiple comparisons, each. 
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4. Discussion  
4.1. Role of altered ambient temperature for SIRS pathogenesis 
Our study identifies ambient temperature as a major impact factor for extent and clinical 
course of LPS-induced SIRS and concomitant BBB breakdown as a key event in the devel-
opment of sepsis-induced brain injury. We studied LPS-induced SIRS at a Ta of 30 °C (within 
thermoneutral zone (Gordon 1991)) and at the upper edge of the recommended standard hous-
ing temperatures for laboratory mice, e.g. at 26 °C (NRC 2011). We show for the first time 
that a reduction of Ta of only 3-4 degrees below the lower critical Ta for mice (Gordon 2017) 
increases the severity of BBB injury as a consequence of LPS-induced SIRS. This was clearly 
associated with a temporary disturbance of thermoregulation as a fundamental homeostatic 
function of all mammals, because body core temperature was markedly reduced early after 
LPS-induced SIRS and hypothermia remained reduced throughout the observed period (Fig. 
4). Occurrence of hypothermia as a result of sepsis/overwhelming systemic inflammation, 
however, characterizes a specific state of disturbed thermoregulation. Indeed, previous exper-
imental and clinical studies clearly showed that severity of inflammation determines direction 
of displacement from normothermia, e.g. mild to moderate SIRS induced by low and medium 
dosages of LPS provoke fever, whereas severe/life-threatening SIRS induces hypothermia 
(Kushimoto et al. 2014; Romanovsky et al. 1996; Rudaya et al. 2005). The mechanisms regu-
lating hypothermia are not fully understood, but cytokines such as tumor necrosis factor-alpha 
(TNFα), interleukins (ILs) and interferon-gamma have been shown to induce or modulate 
hypothermia (Leon 2004). The herein presented data suggest that TNFα may contribute to the 
hypothermic response because of a similar time course. However, other factors play apparent-
ly a more dominant role for the extent of hypothermia early after LPS-induced SIRS induc-
tion. Clearly, Ta determines depth of Tc reduction (Fig. 4). Therefore, hypothermic response 
appears to be a consequence of maladaptive thermoregulation leading to hypometabolism in 
order to avoid hypoxia (Corrigan et al. 2014). Even if this study was not designed to explore 
disturbed thermoregulation due to LPS-induced hypothermia, PI3Kγ-dependent differences in 
extent of sickness suggest that disturbance in behavioral thermoregulation may contribute to 
the manifestation of hypothermia. Small rodents like mice need an increased metabolic rate 
and periodic motor activity for appropriate heat production to maintain homeothermy because 
of its unfavourable surface area vs. mass relation (Cannon and Nedergaard 2011; Gordon 
2017) and develop hypothermia when locomotor activity is diminished due to consequences 
of sickness induced by infection (Jhaveri et al. 2007). Furthermore, mice kept at reduced Ta 
developed an exacerbated and prolonged hypothermia although they exhibited a markedly 
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enhanced sympathetic tone. This might be related to a stronger impairment of thermoregula-
tion with torpor-like traits induced by LPS-induced SIRS (Szentirmai and Krueger 2014) in 
addition to LPS-induced inhibition of brown adipose tissue thermogenesis (Okla et al. 2015). 
The worsening consequences of sickness-induced hypothermia on SIRS-induced SAE and 
other sepsis related organ dysfunctions like septic cardiomyopathia (Ndongson-Dongmo et al. 
in revision), where we could show that moderate reduction of Ta led to a 40% enhanced mor-
tality of mice undergoing LPS-induced SIRS, goes against potential beneficial consequences 
of treatment of critical ill patients with therapeutic hypothermia (i.e. in targeted temperature 
management as part of post-resuscitation care) or induced hypothermia (as used in deep hypo-
thermic circulatory arrest (DHCA) for cardiovascular surgery) (Brown et al. 2012; Paal et al. 
2016). This fundamental difference implies that the treatment-related forms of induced hypo-
thermia are performed by drug-provoked elimination of thermoregulation with prevention of 
shivering and non-shivering heat production that means prevention of extra energy demand 
but use of organ protection by activation numerous signaling pathways preventing hypoxic 
cell loss (Polderman 2009; Yenari and Han 2012). Management of body temperature (Tc) in 
sepsis needs differentiating considerations. The frequently occurring fever enhances inflam-
mation and energy demand (by 10% per extra 1 °C increase) but decrease bacterial and viral 
load. Therefore, normothermia (fever therapy) is regarded to be beneficial when bacterial load 
is controlled by antibiotics (Rice et al. 2005). Whilst the advantages of therapeutic control of 
fever in sepsis remain a controversial topic, there is now good evidence that external cooling 
or treatment with antipyretics to warrant normothermia were safe and effective in septic shock 
(Schortgen et al. 2012; Young et al. 2015). External cooling improves vascular tone, reduces 
oxygen consumption and improved short-term mortality. Treatment with antipyretics im-
proves temporarily cardiovascular function. However, no difference in long-term mortality 
remained.  
 
4.2. Appropriateness of research approaches to study septic encephalopathy 
The complexity of sepsis makes the clinical study of sepsis and sepsis therapeutics diffi-
cult. Animal models have been developed in an effort to create reproducible systems for stud-
ying sepsis pathogenesis, preliminary testing of potential therapeutic agents and different 
components of this multi-faceted life-threatening disease. It is obvious that cerebral dysfunc-
tion in sepsis has been the focus of intense research activity.  
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Meanwhile it is recognized that for translational and therapy-targeted approaches appro-
priate infection models are indispensable (Buras et al. 2005; Dyson and Singer 2009; Rittirsch 
et al. 2007). Several well-standardized experimental approaches are described in order to per-
form an infection which develops a clinical picture associated with many prototypical features 
of sepsis culminating in sepsis associated multi-organ dysfunction. In principle, they can be 
divided into two categories: exogenous administration of a viable pathogen (such as bacteria); 
or alteration of the animal’s endogenous protective barrier (inducing colonic permeability, 
allowing bacterial translocation) (Buras et al. 2005). However, despite its clinical relevance 
and widespread use in sepsis research, one of the major concerns of infection models is con-
sistency (Rittirsch et al. 2009).  
Consequently, for mechanistic approaches with time-critical requirements and attempt to 
verify definable components of sepsis, like the initial infection-induced SIRS, other elaborat-
ed approaches with high-grade standardized animal response are more appropriate. Therefore, 
we used the LPS model where a defined amount of endotoxin is given as systemic administra-
tion via instillation into the abdominal cavity leading to a uniform response of the host (i.e. 
mice mutants) with development of the full picture of infection-induced SIRS. Clearly, this 
approach is based on model of sepsis underlies the notion that it is the host response that 
causes the clinical features of sepsis and not the intact pathogen per se. Endotoxin is part of 
the outer membrane of the cell envelope of gram-negative bacteria. The term endotoxin is 
often used exchangeable with LPS, as LPS represents the main biologically active component 
of endotoxin. The i.v. infusion of LPS as well as its instillation into the abdominal cavity 
causes symptoms of severe infection, accompanied by similarities to pathophysiological re-
sponses in patients with sepsis, such as hematological alterations (Remick et al. 2000). Fur-
thermore, LPS infusion induces an increase of proinflammatory cytokines in serum (Remick 
et al. 1990), another parallel to septic patients, whose elevated cytokine levels correlate with 
severity of the disease (Waage et al. 1987). However, the LPS experimental model and sepsis 
in humans differ in several key points, especially in profile and time course of cytokine re-
lease. Cytokine levels (TNF-α, IL-6, CXC chemokines) peaked much later and occurred at 
much lower levels in human patients with sepsis as well as infection models of sepsis when 
compared with effects of LPS infusion (Cavaillon et al. 2003; Gonnert et al. 2011; Remick et 
al. 2000). Nevertheless, when molecular mechanisms of organ-specific alterations during in-
fection-induced SIRS are target of basic science studies - especially when SIRS is known to 
initiate early disturbances of organ function in sepsis - the LPS model in mouse mutants re-
main one of the most appropriate approaches in order to investigate organ-specific effect in 
intact animals. Of note, this approach enables cell-targeted approaches under comparable ex-
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perimental conditions, e.g. cell-culture studies on primary cells (obtained from the same 
mouse mutants and stimulated with LPS in cell culture) for mechanistic investigations. 
Therefore, we decide to use the LPS model to investigate the role of PI3Kγ in infection-
induced SIRS in order to explore whether or not PI3Kγ is causally involved in pronounced 
BBB disturbance in virtue of SAE. 
 
4.3. Role of PI3Kγ in SIRS-induced SAE 
In a previous study, we have shown that the kinase-independent control of cAMP phos-
phodiesterase activity by PI3Kγ acts as a crucial mediator of microglial cell activation, MMP 
expression and subsequent BBB deterioration (Frister et al. 2014). The data obtained in the 
current study suggest that an aggravated BBB breakdown observed in mice kept at reduced Ta 
during LPS-induced SIRS results from an intensified LPS-induced proinflammatory microgli-
al response with concomitantly pronounced upregulation of brain MMP expression and peri-
vascular MMP-9 release leading to increased PMN invasion with altered microglial migration 
and phagocytosis. These processes appear to be widespread because there were similar find-
ings in quite different brain regions under consideration. Enhanced plasma protein extravasa-
tion in brains obtained from PI3Kγ-deficient mice kept under reduced Ta suggests that the 
genotype-related differences in BBB breakdown appears to be related to microglial activation 
in response to systemic inflammation and concomitant brain tissue MMP upregulation. Com-
pelling evidence suggests that early after SIRS manifestation, constitutive proteases are acti-
vated and begin the process of disassembling the extracellular matrix and opening the BBB 
(Candelario-Jalil et al. 2009; Rosenberg 2012). Immunohistological evaluation revealed that 
there is an increased number of Iba-1 positive cell which co-express MMP-9 in brains ob-
tained from PI3Kγ-deficient mice kept under reduced Ta, which may play a crucial role to 
exacerbate BBB deterioration due to sequential activation by MMP-3 and subsequent attack 
the basal lamina and tight junction proteins (Candelario-Jalil et al. 2009; Gurney et al. 2006). 
Our previous results revealed that the enhanced MMP-9 activity is of microglial origin and 
provoked by a deficient suppressive control of cAMP-dependent signaling in PI3Kγ-deficient 
mice (Frister et al. 2014). MMP-9 is known to act as executing protease for degrading matrix 
substrates and interrupting cell-cell or cell-matrix homeostatic interactions, which may direct-
ly trigger anoikis-like neuronal cell death by interrupting cell-matrix survival signaling (Gu et 
al. 2002). The current findings of aggravated SIRS-induced BBB impairment associated with 
reduced Ta are clearly PI3Kγ-dependent and induce an enhanced invasion of blood born im-
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mune cells and an increased rate of apoptosis when the suppressive effect of PI3Kγ on cAMP 
as a critical mediator of immune cell functions is absent (Figs. 9&10). Causal relations re-
sponsible for associated exacerbated brain injury cannot be drawn conclusively. Nevertheless, 
a reduced ability of directed motility and diminished phagocytic activity in brains obtained 
from PI3Kγ-deficient mice kept under reduced Ta suggest that these altered cell functions 
contribute to the phenotype of enhanced structural and functional cerebral disturbance leading 
to aggravate SAE-associated symptoms. Previous own findings identified the lipid kinase 
activity of PI3Kγ as an essential mediator of microglial migration (Schneble et al. 2017b). 
Furthermore, diminished microglial phagocytic activity appears to contribute to the enhanced 
proinflammatory brain response on LPS-induced SIRS in PI3Kγ-deficient mice kept under 
reduced Ta because microglial phagocytosis represents a key factor for limitation of excessive 
proinflammatory activation by clearance of dying cells and debris in injured brain tissue 
(Kettenmann et al. 2011; Neumann et al. 2009; Schmidt et al. 2016). Therefore, our findings 
support previous reports on inhibition of microglial phagocytosis caused by abnormal high 
cAMP levels though PKA and Epac (Makranz et al. 2006).   
Till now, just few studies have addressed the pathological implications of altered energy 
metabolism including mitochondrial dysfunction in glial cells and its consequences in neuro-
logical disorders (Rose et al. 2017). A proinflammatory phenotype of microglia was recently 
reported to be paralleled by a metabolic switch from mitochondrial oxygen consumption rate 
to glycolysis that enhances carbon flux to the pentose phosphate pathway (Gimeno-Bayon et 
al. 2014; Orihuela et al. 2016; Voloboueva et al. 2013). We found just a minor reduction of 
oxygen consumption rate at neutral Ta. Reasons remained uncertain keeping in mind that the 
previous reported data were obtained from immortalized microglial cell lines whereas we 
studied primary microglial cells. 
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5. Conclusion  
Results clearly underline the importance of ambient temperature as a frequently neglected 
environmental condition in translational work of inflammatory/infectious research. The major 
significance of the of herein presented data is that - despite preadaptation on discrete ambient 
climate conditions - the modest variation of an easily controllable parameter, i.e., ambient 
temperature led to a serious impact in the course of SIRS-associated SAE. Furthermore, our 
data disclose the signaling protein PI3Kγ as a critical mediator of key microglial cell func-
tions involved in LPS-induced BBB injury and accompanied neuroinflammation. PI3Kγ 
serves a protective role in that it suppresses MMP release, maintains microglial motility and 
reinforces phagocytosis leading to improved brain tissue integrity.  
Therefore, PI3K seems a mediator of certain immune functions (phagocytosis, migration, 
MMP production), which are induced by infections and which are accompanied by environ-
mental factors like Ta with potential impact for aggravating inflammatory events.    
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